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Detailed rationale for the simplification of the aplyronines 
 
1.1. Summary of SAR studies conducted to date 
 




Figure 1. Summary of SAR studies conducted for the aplyronines as overlayed onto aplyronine D  
 
1.2. Analysis of the bound Aplyronine A-actin crystal structure 
 
The bound structure of aplyronine A in actin was visualised using Pymol using the Protein 
Databank (PDB) code: 1WUA.3 The ATP binding site of actin is identified with the ATP ligand 
in red. Aplyronine A is denoted in green. 
 
The aplyronine A bound crystal structure of actin verifies the importance of side chain in 
binding to a key binding pocket in actin. The C7 TMSer vital for the activity of aplyronines 
A/D points directly out into bulk solvent, presumably as a binding site to recruit tubulin. It is 
clear that the macrocycle is required to confer overall geometric control, with the northern 
hemisphere appearing to contribute to key contacts with actin. The southern hemisphere 
however did not appear to form relevant contacts as it projects away from both actin and where 
tubulin binds (TMSer) into bulk solvent. Alongside with the SAR study presented above, this 
observation forms the major rationale for our function-oriented simplification of the 
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Figure 2. Annotated figure of the aplyronine-bound actin crystal structure, highlighting the key binding areas of aplyronine 
to the relevant biomolecules, as well as the lack of apparent biological contacts of the southern hemisphere  
Experimental 
 
2. General comments  
 
2.1. General experimental procedures 
 
All experiments were performed under anhydrous conditions and under an inert atmosphere of 
argon, except where stated or when water or aqueous solutions were used, using oven-dried 
apparatus and employing standard techniques for handling air-sensitive materials. 
 
Purification of reagents and solvents was carried out according to standard procedures. 
Acetonitrile (MeCN), benzene, dichloromethane (CH2Cl2), and dimethyl sulfoxide (DMSO) 
were distilled from calcium hydride (CaH2) and stored under an argon atmosphere. 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from benzophenone ketyl 
radical and sodium or potassium wire, respectively, under an argon atmosphere. Solvents used 
in workup, extraction, recrystallisation and column chromatography were distilled prior to use. 
 
Triethylamine (Et3N), pyridine (py), diethyl ethylphosphonate and hexamethyldisilazane 
(HMDS) were distilled from and stored over CaH2. 2,6-lutidine was distilled from CaH2 and 
stored neat under argon. Diisopropylethylamine (iPr2NEt) was first distilled from ninhydrin, 
then distilled from and stored over CaH2. Titanium tetrachloride (TiCl4), titanium 
tetraisopropoxide (Ti(OiPr) 4) and oxalyl chloride ((COCl)2) were distilled and stored at −20 °C 
under an argon atmosphere. Acetaldehyde and propionaldehyde were distilled from calcium 
chloride (CaCl2) immediately prior to use. Proton Sponge was recrystallised from methanol. 
DDQ was recrystallised from chloroform. Barium hydroxide (Ba(OH)2) was dried under high 
vacuum at 130 °C and stored under argon. All other chemicals were used as received, except 
where noted other- wise.  
Sodium bicarbonate (NaHCO3), ammonium chloride (NH4Cl), sodium/potassium (Na+/K+) 
tartrate, brine (NaCl) and sodium thiosulfate (Na2S2O3) were used as saturated aqueous 
solutions, unless otherwise stated in the text. Buffer solutions were prepared as directed from 
stock tablets with deionised water.  
Flash column chromatography was carried out on Merck Kieselgel 60 (230−400 mesh) silica 
gel under a positive pressure of regulated compressed air. Merck Kieselgel F254 plates were 
used for preparative thin layer chromatography. All solvent mixtures are reported as volume 
ratios. Solvents were subsequently evaporated in vacuo. 
2.2. General analytical procedures 
Analytical thin layer chromatography (TLC) was carried out using Merck Kieselgel 60 F254 
plates which were visualised using UV light (254 nm) and stained with potassium 
permanganate, vanillin, anisaldehyde or phosphomolybdic acid / cerium (III) sulfate Ce2(SO4)3 
dips.  
Proton nuclear magnetic resonance (NMR) spectra were recorded using an internal deuterium 
lock at ambient probe temperature (298 K) on the following instruments: Bruker Avance BB, 
or Bruker Avance TCI (500 MHz and Bruker DPX400 (400 MHz). An internal reference of dH 
= 7.26 ppm was used for residual solvent protons in CDCl3 and dH = 7.26 2.50 ppm for DMSO. 
All 1H NMR data are represented as: chemical shift (in ppm on the d scale relative to dTMS = 0 
ppm), integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
br = broad, obs = obscured, app = apparent), coupling constant (J in Hz), and assignment. 
Assignments were determined on the basis of unambiguous chemical shift or coupling pattern, 
1H-1H COSY, HSQC and HMBC experiments, or by analogy to fully interpreted data for 
related compounds.  
Proton-decoupled 13C NMR spectra were recorded using an internal deuterium lock at ambient 
probe temperature (298K) on the following instruments: Bruker Avance BB and Bruker 
Avance TCI (125 MHz). An internal reference of dC = 77.0 ppm was used for carbons in CDCl3 
and dC = 79.5 ppm for DMSO. All chemical shift values are reported in ppm on the d scale 
relative to dTMS = 0 ppm.  
Infrared spectra were recorded on a Perkin-Elmer Spectrum One FT-IR spectrometer. 
Absorbance frequencies (vmax) are reported in cm-1.  
Optical rotations were measured on an Anton Parr MCP100 polarimeter at 589 nm and are 
reported as follows: [!]"#$ 	 at 20 °C (unless otherwise noted), concentration (c in g dL-1) and 
solvent.  
High resolution mass spectra (HRMS) were recorded at the EPSRC Mass Spectrometry Service 
(Swansea, UK) or at the departmental mass spectrometry service (University Chemical 
Laboratories, Cambridge) using electron impact (EI) and electrospray ionization (ESI) 
techniques. The parent ion is quoted with the indicated cation: [M+H]+, [M+Na]+ or [M+NH4]+ 
  
2.3. Compound numbering nomenclature 
The numbering system used for aplyronine intermediates and analogues follows that proposed 
by Yamada and co-workers in their original publication covering the isolation and 
characterisation of the aplyronines as shown below: 
 
 















3. Experimental Procedures for the Synthesis of Aplyrologues 7, R-/S-8 
and 9 
 
3.1. Synthesis of the C15-C27 aldehyde 12 
 
TBS ether 14a 
 
 
To a solution of 1,9-nonanediol (12.0 g, 74.9 mmol) and imidazole (2.04 g, 68.1 mmol) in THF 
(80 mL) at 0 °C was added a solution of TBSCl (3.77 g, 25.0 mmol) in THF (70 mL) dropwise 
over 40 min. The mixture was slowly warmed to rt and allowed to stir for 65 h, then quenched 
by addition of H2O. The phases were separated and the aqueous layer extracted with EtOAc (3 
× 100 mL). The combined organics were washed with H2O (50 mL), dried over Na2SO4 and 
concentrated in vacuo. Purification by flash chromatography (1:3 → 1:2 EtOAc/PE) gave 
alcohol 14a as a colourless oil (5.69 g, 83%).  
 
Rf  0.27 (1:6 EtOAc/PE); 1H NMR (400 MHz, CDCl3) δH 3.64 (2H, t, J = 6.6 Hz, H23), 3.59 
(2H, t, J = 6.6 Hz, H15), 1.61–1.45 (4H, m, H16,H22), 1.39–1.24 (10H, m, H17–21), 0.89 (9H, s, 
SiC(CH3)3), 0.04 (6H, s, Si(CH3)2); 13C NMR (125 MHz, CDCl3) δC 63.3, 63.0, 32.8, 32.8, 
29.6, 29.3, 29.3, 26.0, 25.8, 25.7, 18.4, −5.3; HRMS calc. for C15H35O2Si [M+H]+ 275.2401, 
found 275.2402.  
 






To a solution of oxalyl chloride (2.39 mL, 28.2 mmol) in CH2Cl2 (50 mL) at −78 °C was added 
DMSO (2.67 mL, 37.6 mmol). The mixture was stirred for 30 min, then a solution of alcohol 
14a (5.16 g, 18.8 mmol) in CH2Cl2 (25 mL) was added via cannula and stirred for a further 1 
h. Addition of Et3N (7.86 mL, 56.4 mmol) dropwise at −78 °C caused the reaction mixture to 
seize. After warming to rt with stirring and addition of CH2Cl2 (20 mL), the resulting yellow 
solution was allowed to stir for 16 h. The reaction was quenched carefully with NH4Cl (40 












The combined organics were washed with NaHCO3 (50 mL), dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by flash chromatography (1:15 
EtOAc/PE) to give aldehyde 14 as a colourless oil (4.68 g, 91%). 
  
Rf 0.50 (1:8 EtOAc/PE); 1H NMR (400 MHz, CDCl3) δH 9.76 (1H, t, J = 1.9 Hz, H23), 3.59 
(2H, t, J = 6.6 Hz, H15), 2.41 (2H, td, J = 7.4, 1.9 Hz, H22), 1.68–1.57 (2H, m, H16), 1.55–1.43 
(2H, m, H21), 1.37–1.24 (8H, m, H17–20), 0.89 (9H, s, SiC(CH3)3), 0.04 (6H, s, Si(CH3)2); 
HRMS calc. for C15H33O2Si [M+H]+ 273.2244, found 273.2248.  
 
These data are in agreement with those reported by Cryle et al.7  
 
Aldol adduct 15 
 
   
 
To a solution of TiCl4 (1.37 mL, 12.5 mmol) in CH2Cl2 (50 mL) at 0 °C was added Ti(Oi-Pr)4 
(1.23 mL, 4.17 mmol). The mixture was stirred at 0 °C for 10 min, then at rt for 30 min. The 
resulting colourless solution was added dropwise to a solution of ketone S-13 (3.52 g, 14.9 
mmol, stirred over CaH2 immediately before use) in CH2Cl2 (150 mL) at −78 °C, during which 
the solution gradually turned through yellow to light orange. Dropwise addition of i-Pr2NEt 
(2.85 mL, 16.4 mmol) caused a further colour change to dark red. The reaction mixture was 
stirred at −78 °C for 30 min to allow full enolisation. Aldehyde 14 (4.46 g, 16.4 mmol, stirred 
over CaH2 immediately before use) in CH2Cl2 (100 mL) was then added via cannula down the 
side of the reaction flask over 10 min. Shortly thereafter the solution was observed to return to 
a light orange colour. The mixture was stirred at −78 °C for a further 40 min. Upon completion 
the reaction was quenched with NaHCO3/Na+/K+ tartrate (1:1, 90 mL) and warmed to rt. The 
biphasic mixture was stirred vigorously for 2 h and then left to stand overnight. The layers 
were separated and the organic phase washed with brine (100 mL). The combined aqueous 
fractions were then extracted with EtOAc (2 × 100 mL). The organics were dried over Na2SO4 
and concentrated in vacuo. Purification by flash chromatography (1:10 → 1:5 EtOAc/PE) 
afforded aldol adduct 15 as a colourless oil (6.42 g, 85%, 18:1 dr).  
 
Rf 0.26 (1:5 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 7.18 (2H, d, J = 8.7 Hz, ArH), 6.85 
(2H, d, J = 8.7 Hz, ArH), 4.39 (1H, d, J = 11.4 Hz, ArCHaHbO), 4.36 (1H, d, J = 11.5 Hz, 
ArCHaHbO), 4.00–3.95 (1H, m, H23), 3.79 (3H, s, ArOMe), 3.61 (1H, app t, J = 8.7 Hz, H27a), 











6.9, 4.9 Hz, H26), 2.88 (1H, d, J = 3.9 Hz, C23OH), 2.72 (1H, qd, J = 7.1, 2.7 Hz, H24), 1.50 
(2H, app quint, J = 6.8 Hz, H16 × 2), 1.47–1.34 (2H, m, H22 × 2), 1.34–1.18 (10H, m, H17 – 21 ), 
1.05 (3H, d, J = 7.1 Hz, Me24), 1.00 (3H, d, J = 6.9 Hz, Me26), 0.89 (9H, s, SiC(CH3)3), 0.04 
(6H, s, Si(CH3)2); 13C NMR (125 MHz, CDCl3) δC 218.1, 159.3, 129.6, 129.3, 113.8, 73.1, 
72.9, 70.6, 63.3, 55.2, 50.9, 44.8, 33.6, 32.9, 29.6, 29.6, 29.4, 26.2, 25.9, 25.8, 18.3, 13.6, 8.8, 
−5.3; [!]$"# −2.0 (c 0.10, CHCl3); IR (thin film) νmax (cm–1) 3500, 2929, 2853, 1709, 1615, 
1514, 1461, 1360, 1302, 1249, 1173, 1037, 1005, 991, 834, 777; HRMS calc. for C29H56NO5Si 
[M+NH4]+ 526.3922, found 526.3909.  
 
The configuration at C23 was confirmed by synthesising the diastereomeric Mosher esters 




To a solution of alcohol 15 (10.1 mg, 19.8 μmol) and (S)-α-methoxy-α-
trifluoromethylphenylacetic acid (13.9 mg, 59.4 μmol) in CH2Cl2 (1 mL) was added DCC (60 
μL, 1.0 M in CH2Cl2, 60.0 μmol) followed by DMAP (8.4 mg, 68.8 μmol). The reaction was 
stirred at rt for 19 h, then filtered and concentrated. Flash chromatography (1:30 → 1:20 
EtOAc/PE) gave the (S)-MTPA ester S-MTPA-15 as a colourless oil (10.6 mg, 74%). The 




Rf 0.65 (1:4 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 7.58–7.53 (2H, m, PhH), 7.40–7.36 
(3H, m, PhH), 7.19 (2H, d, J = 8.6 Hz, PMB ArH), 6.85 (2H, d, J = 8.7 Hz, PMB ArH), 5.44 
(1H, app dt, J = 7.6, 5.2 Hz, H23), 4.39 (1H, d, J = 11.6 Hz, ArCHaHbO), 4.33 (1H, d, J = 11.6 
Hz, ArCHaHbO), 3.79 (3H, s, ArOMe), 3.59 (2H, t, J = 6.7 Hz, H15 × 2), 3.56 (1H, dd, J = 8.9, 
8.2 Hz, H27a), 3.52 (3H, s, OMe), 3.39 (1H, dd, J = 9.0, 5.4 Hz, H27b), 3.08–2.99 (1H, m, H26), 
2.93 (1H, dq, J = 7.1, 6.7 Hz, H24), 1.60–1.53 (1H, m, H22a), 1.53–1.43 (3H, m, H16 × 2,H22b), 
1.31–1.10 (10H, m, H17–21), 1.09 (3H, d, J = 7.2 Hz, Me24), 1.03 (3H, d, J = 7.0 Hz, Me26), 
















Rf 0.65 (1:4 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 7.59–7.52 (2H, m, PhH), 7.41–7.35 
(3H, m, PhH), 7.19 (2H, d, J = 8.7 Hz, PMB ArH), 6.85 (2H, d, J = 8.7 Hz, PMB ArH), 5.42 
(1H, app q, J = 6.1 Hz, H23), 4.38 (1H, d, J = 11.5 Hz, ArCHaHbO), 4.34 (1H, d, J = 11.6 Hz, 
ArCHaHbO), 3.79 (3H, s, ArOMe), 3.58 (2H, t, J = 6.7 Hz, H15 × 2), 3.56–3.51 (4H, m, OMe, 
H27a), 3.36 (1H, dd, J = 9.0, 5.4 Hz, H27b), 3.00–2.92 (1H, m, H26), 2.90 (1H, dq, J = 7.3, 6.9 
Hz, H24), 1.62–1.52 (2H, m, H22 × 2), 1.48 (2H, app quint, J = 7.1 Hz, H16 × 2), 1.31–1.12 
(10H, m, H17–21), 1.02 (3H, d, J = 7.2 Hz, Me24), 0.97 (3H, d, J = 7.0 Hz, Me26), 0.89 (9H, s, 
SiC(CH3)3), 0.04 (6H, s, Si(CH3)2).  
 
Table 1. Diagnostic 1H NMR signals for the configurational assignment of 23S 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) 
DdS-R 
(ppm) 
H22a 1.57 1.60 –0.03 
H22b 1.51 1.60 –0.09 
H23 5.44 5.42 +0.02 
H24 2.93 2.90 +0.03 
Me24 1.09 1.02 +0.07 
H26 3.04 2.96 +0.08 







Freshly prepared SmI2 (18.7 mL, ca. 0.1 M in THF, 1.87 mmol) was added dropwise to a 
solution of propionaldehyde (8.1 mL, 112 mmol, distilled from CaCl2 immediately prior to use) 
in THF (120 mL) at 0 °C. The blue-green colour of SmI2 faded upon addition to give a golden 
yellow solution, which was stirred at 0 °C for 15 min then cooled to −20 °C. Ketone 15 (9.34 
g, 18.3 mmol) was dissolved in THF (70 mL) and added to the reaction mixture via cannula. 










to rt. The aqueous fraction was extracted with Et2O (3 × 100 mL). The combined organics were 
dried over Na2SO4, concentrated in vacuo, and purified by flash chromatography (1:15 
EtOAc/PE) to give alcohol 16 as a pale yellow oil (9.91 g, 95%, >20:1 dr).  
 
Rf 0.48 (1:5 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 7.23 (2H, d, J = 8.6 Hz, ArH), 6.87 
(2H, d, J = 8.6 Hz, ArH), 5.27 (1H, ddd, J = 8.7, 5.0, 1.5 Hz, H23), 4.43 (1H, d, J = 11.6 Hz, 
ArCHaHbO), 4.39 (1H, d, J = 11.6 Hz, ArCHaHbO), 3.80 (3H, s, ArOMe), 3.59 (2H, t, J = 6.6 
Hz, H15 × 2), 3.55 (1H, dd, J = 9.2, 5.1 Hz, H27a), 3.43 (1H, dd, J = 9.2, 5.8 Hz, H27b), 3.35 
(1H, d,J=5.7Hz,C25OH),3.10(1H,ddd,J=8.9,5.7,3.5Hz,H25),2.33(2H,q,J=7.6Hz,H2′ ×2), 2.05–
1.98 (1H, m, H26), 1.76 (1H, dqd, J = 8.5, 6.9, 1.3 Hz, H24), 1.72–1.63 (1H, m, H22a), 1.50 (2H, 
app quint, J = 6.9 Hz, H16 × 2), 1.45–1.36 (1H, m, H22 b ), 1.34–1.20 (10H, m, H17 – 21), 1.14 
(3H, t, J = 7.6 Hz, H3′ × 3), 1.06 (3H, d, J = 7.0 Hz, Me26), 0.89 (9H, s, SiC(CH3)3), 0.87 (3H, 
d, J = 6.9 Hz, Me24), 0.04 (6H, s, Si(CH3)2); 13C NMR (125 MHz, CDCl3) δC 175.3, 159.1, 
130.4, 129.1, 113.7, 76.3, 73.7, 72.9, 71.7, 63.3, 55.2, 40.2, 34.7, 32.8, 32.6, 29.5, 29.4, 29.3, 
27.8, 26.0, 26.0, 25.7, 18.3, 16.3, 10.1, 9.3, −5.3; [!]$"# −3.5 (c 1.00, CHCl3); IR (thin film) 
νmax (cm–1) 3504, 2929, 2849, 1728, 1711, 1617, 1514, 1463, 1364, 1247, 1203, 1096, 1039, 
1001, 832, 777; HRMS calc. for C32H62NO6Si [M+NH4]+ 584.4341, found 584.4325.  
 
Methyl ether 16a 
 
Proton Sponge (9.30 g, 43.4 mmol) and Me3O·BF4 (4.28 g, 28.9 mmol) were charged to a flask 
in an argon-filled glove box, then a solution of alcohol 16 (8.17 g, 14.4 mmol) in CH2Cl2 (300 
mL) was added at rt. The reaction was stirred for 3 h, during which time it gradually turned 
yellow, then bright orange. The mixture was then quenched by addition of NH4Cl (150 mL) 
and stirred overnight. The aqueous layer was extracted with CH2Cl2 (3 × 100 mL), then the 
combined organics were washed with citric acid (2 × 200 mL, 10% w/v aq.), dried over MgSO4, 
and concentrated in vacuo. Purification by flash chromatography (1:20 EtOAc/PE) provided 
the methyl ether 16a as a colourless oil (7.42 g, 89%, 99% brsm).  
Rf 0.48 (1:8 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 7.24 (2H, d, J = 8.7 Hz, ArH), 6.86 
(2H, d, J = 8.7 Hz, ArH), 5.18 (1H, app td, J = 7.4, 2.0 Hz, H23), 4.43 (1H, d, J = 11.5 Hz, 
ArCHaHbO), 4.39 (1H, d, J = 11.6 Hz, ArCHaHbO), 3.80 (3H, s, ArOMe), 3.59 (2H, t, J = 6.7 










7.3 Hz, H27b), 2.87 (1H, dd, J = 8.5, 3.6 Hz, H25), 2.31 (2H, q, J = 7.6 Hz, H2′ × 2), 2.12–2.04 
(1H, m, H26), 1.78 (1H, dqd, J = 8.9, 7.0, 2.0 Hz, H24), 1.66–1.58 (1H, m, H22a), 1.49 (2H, app 
quint, J = 7.0 Hz, H16 × 2), 1.46–1.39 (1H, m, H22 b ), 1.33–1.19 (10H, m, H17 – 21 ), 1.14 (3H, 
t, J = 7.6 Hz, H3′ × 3), 1.06 (3H, d, J = 7.1 Hz, Me26), 0.92–0.88 (12H, m, Me24, SiC(CH3)3), 
0.04 (6H, s, Si(CH3)2); 13C NMR (125 MHz, CDCl3) δC 174.1, 159.0, 130.8, 129.0, 113.7, 
85.9, 73.2, 72.7, 71.6, 63.3, 61.3, 55.2, 38.8, 35.9, 32.9, 32.7, 29.5, 29.5, 29.4, 28.0, 26.0, 25.8, 
25.7, 18.4, 16.3, 10.6, 9.4, −5.3; [!]$"# −4.4 (c 0.79, CHCl3); IR (thin film) vmax  (cm-1) 2932, 
2858, D 1732, 1614, 1513, 1463, 1247, 1193, 1090, 1038, 834, 776; HRMS calc. for 
C33H64NO6Si [M+NH4]+ 598.4497, found 598.4482.  
Alcohol 16b 
 
Methyl ether 16a (2.03 g, 3.49 mmol) was dissolved in THF (50 mL) and cooled to 0 °C. HCl 
(30 mL, 1.0 M aq.) was added, then the reaction was stirred at rt. After 1 h the reaction was 
quenched by careful addition of NaHCO3 (80 mL) with cooling in an ice bath. The resulting 
mixture was then diluted with H2O (100 mL) and Et2O (50 mL) and extracted with Et2O (3 × 
100 mL). The combined organics were dried over Na2SO4, concentrated in vacuo, and purified 
by flash chromatography (1:3 EtOAc/PE) to give alcohol 16b as a colourless oil (1.62 g, 99%).  
Rf 0.15 (1:3 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 7.24 (2H, d, J = 8.5 Hz, ArH), 6.86 
(2H, d, J = 8.5 Hz, ArH), 5.18 (1H, app td, J = 7.0, 1.6 Hz, H23), 4.42 (1H, d, J = 11.6 Hz, 
ArCHaHbO), 4.39 (1H, d, J = 11.5 Hz, ArCHaHbO), 3.80 (3H, s, ArOMe), 3.62 (2H, t, J = 6.6 
Hz, H15 × 2), 3.53 (1H, dd, J = 9.2, 4.8 Hz, H27a), 3.37 (3H, s, C25OMe), 3.32 (1H, dd, J = 9.0, 
7.4 Hz, H27b), 2.86 (1H, dd, J = 8.5, 3.5 Hz, H25), 2.31 (2H, q, J = 7.6 Hz, H2′ × 2), 2.12–2.04 
(1H, m, H26), 1.78 (1H, dqd, J = 8.6, 7.1, 1.6 Hz, H24), 1.69–1.59 (1H, m, H22a), 1.55 (2H, app 
quint, J = 6.9 Hz, H16 ×2), 1.47–1.39 (1H, m, H22b), 1.39–1.19 (10H, m, H17–21), 1.14 (3H, t, 
J = 7.6Hz, H3′×3),1.05(3H, d, J = 7.0 Hz, Me26),0.90 (3H, d, J = 7.0 Hz, Me24);13C NMR (125 
MHz, CDCl3) δC 174.1, 159.0, 130.8, 129.0, 113.7, 85.9, 73.1, 72.7, 71.6, 63.0, 61.4, 55.2, 
38.8, 35.9, 32.7, 32.7, 29.4, 29.3, 29.2, 28.0, 25.6, 25.6, 16.3, 10.6, 9.4; [!]$"# −8.0 (c 0.10, D 
CHCl3); IR (thin film) vmax  (cm-1) 3452, 2972, 2933, 2857, 1730, 1613, 1588, 1514, 1463, 
1423, 1364, 1300, 1247, 1195, 1086, 1037, 1003, 820; HRMS calc. for C27H47O6 [M+H]+ 












Oxalyl chloride (381 μL, 4.50 mmol) and CH2Cl2 (40 mL) were charged to a flask and cooled 
to −78 °C. DMSO (426 μL, 6.00 mmol) was added dropwise, and the mixture was stirred for 
30 min. A solution of alcohol 16b (1.41 g, 3.03 mmol) in CH2Cl2 (20 mL) was added and 
stirring continued for 20 min. After addition of Et3N (1.25 mL, 9.00 mmol), the reaction was 
warmed to rt and stirred for 1.5 h. Addition of NH4Cl (60 mL) to quench was followed by 
extraction with Et2O (3 × 50 mL). The combined organics were washed with HCl (100 mL, 
0.5 M aq.), brine (100 mL), and NaHCO3(100 mL), then dried over MgSO4 and concentrated 
in vacuo. The product could be used crude or purified by flash chromatography (1:8 EtOAc/PE) 
to yield the aldehyde 12 as a colourless oil (1.32 g, 94%).  
Rf 0.45 (1:3 EtOAc/PE); 1H NMR (500 MHz, CDCl3) δH 9.75 (1H, t, J = 1.8 Hz, H15), 7.24 
(2H, d, J = 8.6 Hz, ArH), 6.86 (2H, d, J = 8.7 Hz, ArH), 5.17 (1H, app td, J = 7.0, 1.9 Hz, H23), 
4.43 (1H, d, J = 11.5 Hz, ArCH2O), 4.39 (1H, d, J = 11.6 Hz, ArCH2O), 3.80 (3H, s, ArOMe), 
3.53 (1H, dd, J = 9.2, 4.9 Hz, H27a), 3.38 (3H, s, C25OMe), 3.32 (1H, dd, J = 9.1, 7.4 Hz, H27b), 
2.86 (1H, dd, J = 8.5, 3.5 Hz, H25), 2.40 (2H, td, J = 7.4, 1.8 Hz, H16 × 2), 2.31 (2H, q, J = 7.6 
Hz, H2’ × 2), 2.12–2.04 (1H, m, H26), 1.78 (1H, dqd, J = 8.9, 7.0, 1.9 Hz, H24), 1.66–1.58 (3H, 
m, H17 × 2, H22a), 1.47–1.38 (1H, m, H22b), 1.33–1.20 (8H, m, H18-21), 1.14 (3H, t, J = 7.6 Hz, 
H3’ × 3), 1.05 (3H, d, J = 7.0 Hz, Me26), 0.90 (3H, d, J = 7.0 Hz, Me24); 13C NMR (125 MHz, 
CDCl3) δC 202.9, 174.1, 159.0, 130.8, 129.0, 113.7, 85.9, 73.1, 72.7, 71.6, 61.4, 55.3, 43.9, 
38.8, 35.9, 32.7, 29.3, 29.2, 29.0, 28.0, 25.6, 22.0, 16.3, 10.6, 9.4; [!]$"# −5.6 (c 0.65, CHCl3); 
IR (thin film) vmax  (cm-1) 2936, 2858, 1726, 1614, 1511, 1461, 1364, 1247, 1195, 1088, 1038, 











3.2. Synthesis of the C28-C34 side chain E-11 
 
Aldol adduct 17 
 
    
 
To a solution of TiCl4 (175 µL, 1.78 mmol) in CH2Cl2 (8.4 mL) at 0 °C was added Ti(O-iPr)4 
(175 µL, 0.59 mmol). The mixture was stirred at 0 °C for 10 min, then at rt for 20 min. The 
resulting colourless solution was added dropwise to a solution of ketone R-13 (500 mg, 2.12 
mmol, dried under vacuum for 2 h and stirred over CaH2 immediately prior to use) in CH2Cl2 
(13 mL) at -78 °C. To the yellow solution was added i-PrNEt2 (0.41 mL) dropwise and the 
reaction mixture was allowed to enolise at -78 °C for 30 min. Acetaldehyde (1.12 mL, 21.2 
mmol, distilled from CaCl2 immediately prior to use) was dissolved in CH2Cl2 (10 mL) and 
added to the reaction mixture dropwise, causing the deep red solution to gradually turn pale 
orange.  The mixture was stirred at  -78 °C for 30 min before MeOH (8 mL) was added. After 
warming to rt Na+/K+ tartrate was added (20 mL) and the biphasic mixture was vigorously 
stirred overnight. The layers were separated, and the organic phase washed with brine (20 mL) 
and the combined aqueous layers were extracted with CH2Cl2 (3 ´ 20 mL). The combined 
organics were dried (Na2SO4) and concentrated in vacuo and purified by flash column 
chromatography (1:3 EtOAc/PE) to give aldol adduct 17 as a colourless oil (456 mg, 77%, 17:1 
dr). 
 
Rf  0.24 (3:1EtOAc/PE); 1H NMR (400 MHz, CDCl3) dH 7.18 (2H, d, J = 8.6 Hz, ArH), 6.87 
(2H, d, J = 8.9 Hz, ArH), 4.39 (2H, ABq, J = 8.6 Hz, OCH2Ar), 4.19 (1H, qdd, J = 6.6, 4.1, 
3.2 Hz, H29), 3.80 (3H, s, OMe), 3.61 (1H, t, J = 9.1 Hz, H33a), 3.42 (1H, dd, J = 8.7, 4.6 Hz, 
H33b), 3.15 (1H, dqd, J = 9.4, 7.0, 4.7 Hz, H32), 2.94 (1H, d, J = 4.2 Hz, OH), 2.73 (1H, qd, J = 
7.1, 3.0 Hz, H30), 1.12 (3H, d, J = 6.7 Hz, Me28), 1.08 (3H, d, J = 7.1 Hz, Me30), 1.00 (3H, d, J 
= 6.7 Hz, Me32). 










To a solution of propionaldehyde (freshly distilled from CaCl2, 1.54 mL, 21.4 mmol) in THF 
(20 mL) at 0 °C was added freshly prepared SmI2 (2.56 mL, 0.1 M in THF, 0.256 mmol). The 
solution was stirred for 5 min until the deep blue colouration had subsided. A solution of aldol 
adduct 17 (1.00 g, 3.57 mmol) in THF (10 mL) was then added via cannula. The reaction was 
stirred at 0 °C for 1 h, before being quenched with NaHCO3 (10 mL) and extracted with Et2O 
(3 × 10 mL). The combined organic layers were dried (MgSO4), concentrated in vacuo and 
purified by flash column chromatography (1:4 EtOAc/PE) to give alcohol 18 as a colourless 
oil (1.17 g, 97%, >95:5 dr).  
Rf  0.31 (1:4 EtOAc/PE); 1H NMR (400 MHz, CDCl3) (H  7.23 (2H, d, J = 8.4 Hz, ArH), 6.87 
(2H, d, J = 8.7 Hz, ArH), 5.40 (1H, qd, J = 6.6, 2.1 Hz, H29), 4.41 (2H, ABq, J = 11.6 Hz, 
OCH2Ar), 3.80 (3H, s, OMe), 3.54-3.48 (2H, m, H33 × 2), 3.21-3.15 (2H, m, H31, OH), 2.30 
(2H, q, J = 7.7 Hz, H2’ × 2), 2.03-1.94 (1H, m, H32), 1.70-1.59 (1H, m, H30), 1.22 (3H, d, J = 
6.7 Hz, Me28), 1.12 (3H, t, J = 7.5 Hz, H3’ × 3), 1.08 (3H, d, J = 7.0 Hz, Me32), 0.89 (3H, t, J = 
6.9 Hz, Me30). 
These data are in agreement with those reported by Fink et al.8  
Methyl ether 18a 
 
 
To a solution of Meerwein salt (Me3OBF4, 874 mg, 5.92 mmol) and Proton Sponge® (1.90 g, 
8.88 mmol) in CH2Cl2 (50 mL) was added alcohol 18 (1.00 g, 2.96 mmol). The reaction was 
stirred for 4 h before being quenched with NH4Cl (100 mL). The layers were separated, and 
the aqueous phase extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were dried 
(MgSO4), concentrated in vacuo and purified by flash column chromatography (1:4 EtOAc/PE) 
to give methyl ether 18a as a colourless oil (0.939 g, 90%). 
Rf  0.29 (1:3 EtOAc/PE); 1H NMR (400 MHz, CDCl3) (H  7.24 (2H, d, J = 8.6 Hz, ArH), 6.87 
(2H, d, J = 8.6 Hz, ArH), 5.27-5.20 (1H, m, H29), 4.41 (2H, ABq, J = 11.7 Hz, OCH2Ar), 3.80 













2.3 Hz, H33b), 2.89 (1H, dd, J = 8.8, 3.2 Hz, H31), 2.30 (2H, q, J = 7.8 Hz, H2’ × 2), 2.12-2.03 
(1H, m, H32), 1.74-1.66 (1H, m, H30), 1.21 (3H, d, J = 6.0 Hz, Me28), 1.21 (3H, t, J = 7.6 Hz, 
H3’ × 3), 1.10 (3H, d, J = 6.7 Hz, Me32), 0.94 (3H, t, J = 7.4 Hz, Me30). 13C NMR (125 MHz, 
CDCl3) (C 173.8, 158.9, 130.7, 128.9, 113.6, 85.9, 72.6, 71.3, 69.6, 61.3, 55.1, 40.8, 35.8, 27.9, 
18.2, 16.2, 10.3, 9.2; [!]$"# +2.3 (c 0.98, CHCl3); IR (thin film) vmax  (cm-1) 2974, 2937, 1731, 
1613, D 1513, 1462, 1367, 1302, 1246, 1195, 1172, 1083, 1036, 1011, 819; HRMS calc. for 





To a solution of PMB ether 18a (380 mg, 1.08 mmol) in CH2Cl2 (12 mL) was added pH 7.0 
buffer (6 mL) and DDQ (490 mg, 2.16 mmol) at 0 °C. The reaction was warmed to rt and 
stirred for 1 h before being quenched with NaHCO3 (15 mL). The layers were separated, and 
the aqueous phase was extracted with EtOAc (3 × 15 mL). The combined organics were dried 
(Na2SO4) and concentrated in vacuo. The crude material was purified by flash column 
chromatography (1:3 EtOAc/PE) to yield alcohol 18b as a colourless oil (245 mg, 93%). 
 
Rf  0.21 (1:3 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 5.24 (1H, dq, J = 6.5, 2.5 Hz, H29), 
3.84-3.78 (1H, m, H33a), 3.58-3.52 (1H, m, H33b), 3.47 (3H, s, OMe), 2.98 (1H, dd, J = 8.8, 3.2 
Hz, H31), 2.78 (1H, br s, OH), 2.32 (2H, q, J = 7.8 Hz, H2’ × 2), 1.92-1.85 (1H, m, H32), 1.82-
1.75 (1H, m, H30), 1.24 (3H, d, J = 6.5 Hz, Me28), 1.15 (3H, d, J = 7.2 Hz, Me32), 1.14 (3H, t, 
J = 7.5 Hz, H3’ × 3), 0.92 (3H, d, J = 7.0 Hz, Me30). 13C NMR (125 MHz, CDCl3) (C 173.9, 
88.6, 69.6, 64.5, 61.7, 41.3, 36.0, 28.0, 18.3, 16.0, 10.3, 9.2;; [!]$"# 8.8 (c 1.00, CHCl3); IR 
(thin film) vmax  (cm-1) 3425, 2977, 2938, 2881, 2829, 1731, 1462, 1376, 1276, 1194, 1158, 







To a solution of ester 18b (233 mg, 1.00 mmol) in CH2Cl2 (10 mL) was added DIBAL (4 mL, 











Na+/K+ tartrate (20 mL) and allowed to warm to rt. The layers were separated and the aqueous 
was extracted with CH2Cl2 (4 × 30 mL) and the combined organics were dried (Na2SO4) and 
concentrated in vacuo. The crude was purified by flash column chromatography (1:1 
EtOAc/PE) to afford diol 19 as a colourless oil (153 mg, 87%). 
 
Rf  0.20 (1:1 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 4.19 (1H, q, J = 6.7 Hz, H29), 3.76-
3.64 (2H, m, H33 × 2), 3.56 (3H, s, OMe), 3.18 (1H, dd, J = 7.7, 4.5 Hz, H31), 2.95 (1H, br s, 
OH), 2.27 (1H, br s, OH), 2.02-1.95 (1H, m, H32), 1.71-1.64 (1H, m, H30), 1.56 (3H, d, J = 6.4 
Hz, Me28), 1.03 (3H, d, J = 7.2 Hz, Me32), 0.96 (3H, d, J = 6.7 Hz, Me30); 13C NMR (125 MHz, 
CDCl3) (C 90.6, 66.6, 65.3, 61.8, 39.7, 37.6, 20.7, 14.9, 11.0; [!]$"# +8.5 (c 1.00, CHCl3); IR 
(thin film) vmax  (cm-1) 3217, 2972, 2930, 1456, 1370, 1076, 1032, 1010, 998, 937, 900; HRMS 




   
To a solution of DMSO (0.52 mL, 7.38 mmol) in CH2Cl2  (10 mL) at –78 °C was added oxalyl 
chloride (0.31 mL, 3.69 mmol). After stirring for 30 min, a solution of diol 19 (216 mg, 1.23 
mmol) in CH2Cl2 (10 mL) was added. The mixture was stirred for 30 min and then 
triethylamine (2.06 mL, 14.7 mmol) was added. The reaction mixture was stirred at –78 °C for 
30 min, then warmed to rt for 1 h before being quenched with NH4Cl solution (15 mL). The 
layers were separated, and the aqueous phase was extracted with Et2O (3 × 15 mL). The 
combined organics were dried over MgSO4 and concentrated in vacuo to afford aldehyde 20 
(180 mg, 85%) which was used immediately crude in the subsequent Wittig reaction.  
To a suspension of phosphonium salt 21 (4.48 g, 11.3 mmol) in THF (25 mL) at –78 °C was 
added freshly prepared LiHMDS (12.5 mL, 1.0 M in THF, 12.5 mmol). The ylide solution was 
stirred at –78 °C for 30 min, warmed to –40 °C and stirred for 30 min, warmed to –20 °C and 
stirred for 30 min and finally warmed to 0 °C for 20 min after which the yellow suspension 
was cooled back down to –78 °C. A solution of ketoaldehyde 20 (976 mg, 5.67 mmol, pre-
dried over CaH2 for 1 h) in THF (25 mL) was added slowly. The reaction mixture was stirred 
at –78 °C for 2 h before being quenched with pH 7.0 buffer (50 mL) and diluted with Et2O (10 
mL). The layers were separated and the aqueous layer extracted with EtOAc (3 × 50 mL). The 
combined organics were dried over MgSO4 and concentrated in vacuo. The crude material was 
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21
yellow oil as an inseparable mixture of geometric isomers (800 mg, 62% over 2 steps, 3:1 Z/E).  
While a full characterisation has been carried out for enamide E/Z-11, an analytically pure 
sample for spectroscopic characterisation was obtained, and a spectroscopically pure sample 
was only obtained for E-11 after the I2-mediated isomerisation, described below. 
Rf  0.27 (1:1 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H  8.10 (0.85H, s, NCHO), [8.01] (0.1H, 
s, NCHO*), [6.19] (0.12H, d, J = 9.1 Hz, H34*), 5.92 (0.81H, d, J = 8.7 Hz, H34), 5.27 (0.84H, 
dd, J = 10.8, 8.7 Hz, H33), [5.24-5.19] (0.13H, m, H33*), 3.32 (3H, s, OMe), 3.20 (1H, dd, J = 
9.4, 3.1 Hz, H31), [2.98] (0.15H, s, NMe*), 2.95 (2.45H, s, NMe), [2.74-2.68] (0.16H, m, H32*), 
2.67-2.57 (2H, m, H32, H30),  2.14 (3H, s, Me28), 1.09 (3H, d, J = 7.0 Hz, Me30), [0.88] (0.67H, 
d, J = 7.0 Hz, Me32*), 0.84 (2.40H, d, J = 7.0 Hz, Me32); 13C NMR (125 MHz, CDCl3) (C 
[212.4], 211.8, 162.5, [162.4], 127.7, 125.1, [124.5], [124.1], [87.2], 86.9, [61.2], 61.3, [49.7], 
49.8, 36.2, [34.9], 33.8, 31.5, [31.1], 30.9, 19.0, [18.3], [13.4], 13.2; [!]$"#  +11.0 (c 1.00, 
CHCl3); IR (thin film) vmax  (cm-1) 2972, 2929, 1682, 1653, 1457, 1355, 1088, 1054; HRMS 
calc. for C12H21NO3Na [M+Na]+ 250.1414, found 250.1412. 
 
Distinguishable resonances of the minor rotamer (3:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 
C28-C34 fragment E-11 
 
Enamide E/Z-86 (810 mg, 3.56 mmol) was dissolved in CH2Cl2 (100 mL) and a solution of 
iodine (45 mg, 0.18 mmol) in CH2Cl2 (20 mL) was added. The reaction mixture was stirred in 
the dark at room temperature for 16 h before being quenched with sodium thiosulfate (100 mL, 
sat. aq.). The biphasic mixture was stirred rapidly for 2 h and the organic layer separated. The 
aqueous phase was extracted with CH2Cl2 (3 × 50 mL) and the combined organics dried 
(MgSO4) and concentrated in vacuo. The crude was purified by flash column chromatography 
(1:1 EtOAc/PE) to afford (E)-enamide 11 as a pale-yellow oil (700 mg, 86%, >20:1 E/Z).   
Rf  0.27 (1:1 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 8.25 (0.59H, s, NCHO),  [8.04] 
(0.33H, s, NCHO*), [7.09] (0.32H, d, J = 14.5 Hz, H34*), 6.44 (0.59H, d, J = 14.5 Hz, H34), 
5.09 (1H, dd, J = 14.5, 8.5 Hz, H33), 3.34 (3H, s, OMe), 3.26 (1H, dd, J = 10.5, 2.7 Hz, H31), 
[3.04] (1H, s, NMe*), 3.00 (2H, s, NMe), 2.72-2.61 (1H, m, H32), 2.44-2.31 (1H, m, H30), 2.16 
(3H, s, Me28), 1.12 (3H, d, J = 6.7 Hz, Me32), 0.92 (3H, d, J = 7.1 Hz, Me30); 13C NMR (125 
MHz, CDCl3) (C [212.4], 212.3, 162.1, 160.8, 128.7, 124.7, [113.1], 111.3, [87.4], 87.3, 61.2, 







0.84, CHCl3); IR (thin film) vmax  (cm-1) 2964, 2928, 1691, 1651, 1457, 1353, 1318, 1275, 1193, 
1170, 1092, 1068, 956, 725; HRMS calc. for C12H21NO3Na [M+Na]+ 250.1414, found 
250.1412.  
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 




   
 
To Ba(OH)2 (592 mg, 3.46 mmol) was added a solution of phosphonate 13 (2.24 g, 2.88 mmol, 
3:1 mixture with regioisomer 77) in THF (40 mL) and the suspension was stirred for 1 h at rt. 
Aldehyde 12 (1.10 g, 2.37 mmol) in THF/H2O (40:1, 25 mL) was added and the reaction was 
stirred for 72 h. The reaction was quenched by the addition of NH4Cl (75 mL) and the layers 
separated. The aqueous phase was extracted with EtOAc (3 × 100 mL) and the combined 
organics were dried (MgSO4) and concentrated in vacuo. The crude material was purified by 
flash column chromatography (1:5 ® 1:4 EtOAc/PE) to yield enone 22 (1.96 g, 85% >20:1) 
as a colourless oil. 
Rf 0.76 (1:3 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 7.24 (2H, d, J = 8.5 Hz, ArH), 6.86 
(2H, d, J = 8.5 Hz, ArH), 6.59 (1H, t, J = 7.1 Hz, H15), 6.18 (1H, dd, J = 14.9, 10.5 Hz, H3), 
6.04 (1H, dd, J = 15.2, 10.5 Hz, H4), 5.68 (1H, dt, J = 14.7, 7.5 Hz, H5), 5.64 (1H, dt, J = 14.7, 
5.7 Hz, H2), 5.18 (1H, td, J = 6.7, 2.0 Hz, H23), 4.41 (2H, ABq, J = 11.0 Hz, OCH2Ar), 4.20 
(2H, d, J = 5.1 Hz, H1 × 2), 3.80 (3H, s, OMe), 3.66-3.60 (1H, m, H7), 3.56-3.51 (2H, m, H9, 
H27a), 3.38 (3H, s, OMe), 3.32 (1H, dd, J = 8.9, 7.2 Hz, H27b), 2.87 (1H, dd, J = 8.8, 3.8 Hz, 
H25), 2.73 (1H, ddd, J = 15.7, 9.7, 6.0 Hz, H12a), 2.56 (1H, ddd, J = 15.7, 9.7, 6.0 Hz, H12b), 
2.31 (2H, q, J = 7.6 Hz, H2’ × 2), 2.21 (2H, q, J = 7.4 Hz, H16 × 2), 2.18-2.14 (2H, m, H6 × 2), 
2.11-2.06 (1H, m, H26), 1.81-1.70 (3H, m, H8, H11a, H24), 1.76 (3H, s, Me14), 1.67-1.58 (1H, m, 
H22a), 1.48-1.37 (4H, m, H11b, H22b, H17 × 2 ), 1.34-1.20 (8H, m, H18-21), 1.14 (3H, t, J = 7.6 Hz, 

















8.2 Hz, Si(CH2CH3)3), 0.92-0.89 (15H, m, SiC(CH3)3, Me24, Me10), 0.86 (3H, d, J = 6.9 Hz, 
Me8), 0.61 (6H, q, J = 7.8 Hz, Si(CH2CH3)3), 0.56 (6H, q, J = 7.5 Hz, Si(CH2CH3)3), 0.07 (6H, 
s, Si(CH3)2). 13C NMR (125 MHz, CDCl3) (C 202.1, 174.1, 159.0, 142.1, 137.1, 131.5, 131.4, 
130.9, 130.3, 130.3, 129.0, 113.7, 85.9, 77.5, 74.5, 73.1, 72.8, 71.6, 63.7, 61.4, 55.2, 41.8, 38.9, 
38.2, 36.0, 35.9, 35.4, 32.8, 29.5, 29.5, 29.4, 29.1, 28.7, 28.0, 26.9, 26.0, 25.8, 18.4, 16.3, 16.3, 
11.4, 10.6, 10.5, 9.4, 7.2, 7.0, 5.6, 5.3, −5.2;  [!]$"# –2.6 (c 1.01, CHCl3);  IR (thin film) νmax 
(cm–1) 2952, 2931, 2876, 2857, 1732, 1670, 1614, 1513, 1461, 1378, 1247, 1192, 1083, 1040, 






To a solution of enone 22 (1.96 g, 1.80 mmol) in THF (47 mL) was added (R)-Me-CBS catalyst 
(2.16 mL, 1 M in PhMe, 2.16 mmol) at –10 °C and the solution stirred for 5 min before 
dropwise addition of BH3×SMe2 (188 μL, 1.98 mmol). The solution was stirred at –10 °C for 
1.5 h then carefully quenched by the addition of MeOH (50 mL). The solution was warmed to 
rt and concentrated in vacuo. The residue was re-dissolved in MeOH (40 mL) and was again 
concentrated in vacuo. This process was repeated twice further. Purification via flash column 
chromatography (1:6 EtOAc/PE) gave alcohol 22a (1.79 g, 93%, >20:1 dr) as a colourless oil. 
Rf 0.72 (1:3 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 7.24 (2H, d, J = 8.5 Hz, ArH), 6.86 
(2H, d, J = 8.5 Hz, ArH), 6.18 (1H, dd, J = 15.2, 10.4 Hz, H3), 6.04 (1H, dd, J = 15.3, 10.2 Hz, 
H4), 5.68 (1H, dt, J = 14.7, 7.4 Hz, H5), 5.64 (1H, dt, J = 15.3, 5.6 Hz, H2), 5.36 (1H, t, J = 6.4 
Hz, H15), 5.18 (1H, td, J = 7.2, 1.8 Hz, H23), 4.41 (2H, ABq, J = 11.1 Hz, OCH2Ar), 4.20 (2H, 
d, J = 5.2 Hz, H1 × 2), 3.94 (1H, td, J = 6.6, 2.5 Hz, H13), 3.80 (3H, s, OMe), 3.62-3.58 (1H, m, 
H7), 3.53 (1H, dd, J = 9.2, 4.8 Hz, H27a), 3.50 (1H, dd, J = 5.1, 3.5 Hz, H9), 3.38 (3H, s, OMe), 
3.32 (1H, dd, J = 9.1, 7.4 Hz, H27b), 2.87 (1H, dd, J = 8.6, 3.4 Hz, H25), 2.31 (2H, q, J = 7.7 Hz, 
H2’ × 2), 2.18-2.12 (2H, m, H6 × 2), 2.12-2.06 (1H, m, H26), 2.03-1.94 (2H, m, H16 × 2), 1.82-
1.70 (2H, m, H8, H24), 1.66-1.60 (2H, m, H12a, H22a), 1.58 (3H, br s, Me14), 1.54-1.48 (1H, m, 
H10), 1.48-1.37 (4H, m, H11 × 2, H12b, H22b), 1.35-1.29 (2H, m, H17 × 2), 1.29-1.24 (8H, m, H18-
21), 1.14 (3H, t, J = 7.6 Hz, H3’ × 3), 1.05 (3H, d, J = 7.0 Hz, Me26), 0.96 (9H, t, J = 8.0 Hz, 
Si(CH2CH3)3), 0.93 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.91 (9H, s, SiC(CH3)3), 0.90-0.84 (9H, 











Si(CH2CH3)3), 0.07 (6H, s, Si(CH3)2). 13C NMR (125 MHz, CDCl3) (C 174.1, 159.0, 136.7, 
131.6, 131.4, 130.8, 130.3, 130.3, 129.0, 127.5, 113.7, 85.9, 78.7, 77.6, 74.6, 73.1, 72.7, 71.6, 
63.7, 61.3, 55.2, 41.7, 38.8, 38.5, 35.9, 35.9, 33.0, 32.7, 29.5, 29.5, 29.4, 29.3, 28.0, 27.8, 27.5, 
25.9, 25.7, 18.4, 16.3, 16.2, 10.8, 10.6, 10.3, 9.4, 7.1, 7.0, 5.6, 5.2, −5.2; [!]$"#  +1.9 (c 1.01, 
CHCl3); IR (thin film) νmax (cm–1) 2952, 2930, 2876, 2856, 1733, 1614, 1514, 1462, 1378, 
1362, 1248, 1193, 1084, 1041, 1005, 990, 835, 776, 737, 725; HRMS calc. for C62H120O9Si3N 
[M+NH4]+ 1106.8265, found 1106.8257.	 








To a solution of Meerwein salt (143 mg, 0.96 mmol) and proton sponge (309 mg, 1.44 mmol) 
in CH2Cl2 (30 mL) was added alcohol 22a (525 mg, 0.48 mmol). The reaction was stirred for 
4 h at rt before being quenched with NH4Cl (50 mL). The layers were separated, and the 
aqueous phase extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were dried 
(MgSO4), concentrated in vacuo and purified by flash column chromatography (1:20 ® 1:9 
EtOAc/PE) to give methyl ether 23 as a colourless oil (445 mg, 87%). 
Rf 0.79 (1:3 EtOAc/PE); 1H NMR (400 MHz, CDCl3) (H 7.24 (2H, d, J = 8.7 Hz, ArH), 6.86 
(2H, d, J = 8.7 Hz, ArH), 6.18 (1H, dd, J = 14.9, 10.6 Hz, H3), 6.03 (1H, dd, J = 15.3, 10.6 Hz, 
H4), 5.68 (1H, dt, J = 14.8, 7.1 Hz, H5), 5.64 (1H, dt, J = 14.8, 5.9 Hz, H2), 5.31 (1H, t, J = 7.2 
Hz, H15), 5.18 (1H, td, J = 7.2, 1.7 Hz, H23), 4.41 (2H, ABq, J = 11.6 Hz, OCH2Ar), 4.20 (2H, 
d, J = 5.0 Hz, H1 ´ 2), 3.80 (3H, s, OMe), 3.62-3.56 (1H, m, H7), 3.53 (1H, dd, J = 8.9, 4.5 Hz, 
H27a), 3.48 (1H, dd, J = 5.0, 3.2 Hz, H9), 3.38 (3H, s, OMe), 3.36-3.30 (2H, m, H13, H27b), 3.14 
(3H, s, OMe), 2.87 (1H, dd, J = 8.2, 3.9 Hz, H25), 2.31 (2H, q, J = 7.6 Hz, H2’ × 2), 2.19-2.12 
(2H, m, H6 × 2), 2.12-1.93 (3H, m, H16 × 2, H26), 1.83-1.68 (2H, m, H8, H24), 1.68-1.57 (2H, m, 
H12a, H22a), 1.54-1.40 (4H, m, H10, H12 × 2, H22b), 1.49 (3H, s, Me14), 1.39-1.31 (4H, m, H11 × 
2, H17 × 2), 1.31-1.24 (8H, m, H18-21), 1.14 (3H, t, J = 7.4 Hz, H3’ × 3), 1.06 (3H, d, J = 7.1 Hz, 
Me26), 0.94 (9H, t, J = 8.1 Hz, Si(CH2CH3)3), 0.93 (9H, t, J = 8.1 Hz, Si(CH2CH3)3), 0.91 (9H, 
s, SiC(CH3)3), 0.90-0.83 (9H, m, Me8, Me10, Me24), 0.60 (6H, q, J = 7.6 Hz, Si(CH2CH3)3), 
0.57 (6H, q, J = 7.6 Hz, Si(CH2CH3)3), 0.07 (6H, s, Si(CH3)2). 13C NMR (125 MHz, CDCl3) 
(C 174.1, 159.0, 133.8, 131.7, 131.3, 130.9, 130.3, 130.3, 129.6, 129.0, 113.7, 88.3, 85.9, 77.6, 
74.7, 73.1, 72.8, 71.6, 63.7, 61.4, 55.5, 55.2, 41.7, 38.9, 38.6, 35.9, 35.8, 32.8, 31.8, 29.6, 29.6, 










5.2; [!]$"# +1.5 (c 0.89, CHCl3); IR (thin film) νmax (cm–1) 2952, 2926, 2876, 2855, 1734, 1615, 
1514, 1462, 1378, 1362, 1248, 1192, 1171, 1093, 1043, 1006, 990, 836, 776, 739, 725; HRMS 








To a solution of ester 23 (1.58 g, 1.43 mmol) in CH2Cl2 (28 mL) was added DIBAL (2.86 mL, 
2.86 mmol, 1.0 M in hexanes) at –78 °C. After 1.5 h, the reaction was quenched with NH4Cl 
(25 mL) and Na+/K+ tartrate (25 mL) and allowed to warm to rt. The layers were separated and 
the aqueous was extracted with CH2Cl2 (3 × 25 mL) and the combined organics were dried 
(Na2SO4) and concentrated in vacuo. The crude was purified by flash column chromatography 
(1:4 EtOAc/PE) to afford alcohol 23a as a colourless oil (1.51 g, 99%). 
 
Rf 0.62 (1:3 EtOAc/PE); 1H NMR (400 MHz, CDCl3) (H 7.26 (2H, d, J = 8.9 Hz, ArH), 6.88 
(2H, d, J = 8.6 Hz, ArH), 6.18 (1H, dd, J = 15.2, 10.7 Hz, H3), 6.04 (1H, dd, J = 15.2, 10.7 Hz, 
H4), 5.68 (1H, dt, J = 14.4, 7.0 Hz, H5), 5.64 (1H, dt, J = 15.2, 5.0 Hz, H2), 5.31 (1H, t, J = 7.0 
Hz, H15), 4.44 (2H, s, OCH2Ar), 4.20 (2H, d, J = 5.4 Hz, H1 × 2), 3.89 (1H, t, J = 6.6 Hz, H23), 
3.80 (3H, s, OMe), 3.62-3.56 (1H, m, H7), 3.54-3.50 (1H, m, H27a), 3.50-3.46 (3H, m, H9, H27b, 
OH,), 3.44 (3H, s, OMe), 3.34 (1H, t, J = 7.1 Hz, H13), 3.19 (1H, dd, J = 9.0, 3.0 Hz, H25), 3.14 
(3H, s, OMe), 2.19-2.10 (2H, m, H6 × 2), 2.10-1.97 (3H, m, H26, H16 × 2), 1.76-1.70 (2H, m, 
H8, H24), 1.55-1.44 (4H, m, H10, H12 × 2, H22a), 1.49 (3H, s, Me14), 1.41-1.31 (5H, m, H11 × 2, 
H17 × 2, H22b), 1.31-1.26 (8H, m, H18-21), 1.04 (3H, d, J = 6.9 Hz, Me24), 0.95 (9H, t, J = 8.1 
Hz, Si(CH2CH3)3), 0.94 (9H, t, J = 8.1 Hz, Si(CH2CH3)3), 0.94-0.91 (3H, obs m, Me26), 0.91 
(9H, s, SiC(CH3)3), 0.87 (3H, d, J = 7.5 Hz, Me10), 0.85 (3H, d, J = 7.6 Hz, Me8), 0.60 (6H, q, 
J = 8.0 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 8.1 Hz, Si(CH2CH3)3), 0.07 (6H, s, Si(CH3)2). 13C 
NMR (125 MHz, CDCl3) (C 159.1, 133.7, 131.7, 131.3, 130.6, 130.3, 130.2, 129.6, 129.1, 
113.7, 89.0, 88.2, 77.6, 74.7, 72.7, 72.0, 70.6, 63.7, 61.7, 55.5, 55.2, 41.6, 38.6, 37.1, 36.7, 
35.8, 34.7, 31.7, 29.8, 29.6, 29.5, 29.4, 27.9, 28.5, 26.2, 25.9, 18.4, 16.0, 14.9, 11.4, 10.2, 10.0, 
7.1, 7.0, 5.6, 5.2, 5.2; [!]$"# 1.8 (c 1.01, CHCl3) ); IR (thin film) νmax (cm–1) 3507, 2952, 2928, 
2876, 2853, 1613, 1514, 1460, 1413, 1377, 1359, 1300, 1246, 1169, 1084, 1042, 1006, 990, 
















To a solution of TBS ether 23a (836 mg, 0.80 mmol) in CH2Cl2 (12 mL) and pH 9.2 buffer (3 
mL) at 0 °C was added DDQ (200 mg, 0.88 mmol). The solution was stirred at this temperature 
for 15 min, then quenched with NaHCO3 (60 mL) and warmed to rt. The mixture was extracted 
with CH2Cl2 (3 × 50 mL) and the combined organics were dried (Na2SO4) and concentrated in 
vacuo. Purification via flash column chromatography (1:6 EtOAc/PE) gave aldehyde 23b (560 
mg, 75%, 91% brsm) as a colourless oil.  
Rf 0.62 (1:3 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 9.55 (1H, d, J = 7.9 Hz, H1), 7.25 
(2H, d, J = 7.8 Hz, ArH), 7.08 (1H, dd, J = 15.3, 10.1 Hz, H3), 6.88 (2H, d, J = 8.5 Hz, ArH), 
6.34-6.28 (2H, m, H4, H5), 6.08 (1H, dd, J = 15.4, 8.2 Hz, H2), 5.31 (1H, t, J = 7.0 Hz, H15), 
4.43 (2H, s, OCH2Ar), 3.90 (1H, app t, J = 6.6 Hz, H23), 3.81 (3H, s, OMe), 3.70-3.63 (1H, m, 
H7), 3.55-3.45 (4H, m, H9, H27 ´ 2, OH), 3.44 (3H, s, OMe), 3.34 (1H, t, J = 6.1 Hz, H13), 3.18 
(1H, dd, J = 9.3, 3.7 Hz, H25), 3.14 (3H, s, OMe), 2.37-2.24 (2H, m, H6 × 2), 2.11-1.93 (3H, m, 
H16 × 2, H26), 1.80-1.71 (1H, m, H8), 1.71-1.64 (1H, m, H24), 1.57-1.51 (4H, m, H10, H22a, H12 
× 2), 1.49 (3H, s, Me14), 1.45-1.33 (5H, m, H17 × 2, H11 × 2, H22b), 1.33-1.25 (8H, m, H18-21), 
1.04 (3H, d, J = 7.1 Hz, Me24), 0.95 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.94 (9H, t, J = 7.9 Hz, 
Si(CH2CH3)3), 0.93 (3H, obs d, J = 7.8 Hz, Me26), 0.88 (3H, d, J = 6.8 Hz, Me10), 0.87 (3H, d, 
J = 6.8 Hz, Me8), 0.60 (6H, q, J = 7.8 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 7.8 Hz, 
Si(CH2CH3)3) ); 13C NMR (125 MHz, CDCl3) (C 193.9, 159.1, 152.5, 144.8, 133.7, 130.6, 
130.3, 130.2, 129.6, 129.2, 113.7, 89.0, 88.2, 77.4, 74.3, 72.7, 72.0, 70.6, 61.7, 55.5, 55.2, 41.5, 
38.9, 37.1, 36.7, 36.4, 34.7, 31.8, 29.8, 29.6, 29.5, 29.4, 28.3, 27.5, 26.2, 15.9, 14.9, 11.4, 10.1, 
10.0, 7.1, 6.9, 5.6, 5.1; [!]$"# 2.4 (c 1.01, CHCl3); IR (thin film) νmax (cm–1) 3486, 2952, 2931, 
2876, 2853, 1685, 1640, 1613, 1514, 1459, 1416, 1378, 1367, 1302, 1247, 1171, 1159, 1087, 

















To aldehyde 23b (510 mg, 0.55 mmol) was added 2-methyl-2-butene (8.71 mL, 82.6 mmol) 
and the solution was cooled to 0 °C. NaClO2 (1.86 g, 80% technical grade, 16.4 mmol) and 
NaH2PO4×H2O (3.43 g, 22 mmol) were dissolved in H2O/t-BuOH (34 mL, 1:1) and added to 
the reaction mixture. The reaction was warmed to rt and stirred for 16 h before being diluted 
with EtOAc (50 mL) and brine (50 mL). The mixture was extracted with EtOAc (3 × 10 mL) 
and the combined organics were dried (Na2SO4) and concentrated in vacuo to give seco-acid 
24 (ca. 521 mg) as a pale-yellow oil. The crude material was used directly in the next reaction 
without further purification.  
Rf 0.21 (1:4:1 EtOAc/PE/AcOH); 1H NMR (500 MHz, CDCl3) (H 7.32 (1H, dd, J = 15.2, 9.9 
Hz, H3), 7.25 (2H, d, J = 8.5 Hz, ArH), 6.88 (2H, d, J = 8.5 Hz, ArH), 6.27-6.12 (2H, m, H4, 
H5), 5.79 (1H, d, J = 15.5 Hz, H2), 5.31 (1H, t, J = 7.0 Hz, H15), 4.44 (2H, s, OCH2Ar), 3.98-
3.91 (1H, t, J = 7.1 Hz,  H23), 3.81 (3H, s, OMe), 3.67-3.60 (1H, m, H7), 3.55-3.40 (2H, m, H9, 
H27b), 3.49-3.45 (1H, m, H27b), 3.45 (3H, s, OMe), 3.35 (1H, t, J = 6.9 Hz, H13), 3.19 (1H, dd, 
J = 8.8, 3.1 Hz, H25), 3.14 (3H, s, OMe), 2.31-2.22 (2H, m, H6 × 2), 2.12-2.06 (2H, m, H16a, 
H26), 2.01-1.93 (1H, m, H16b), 1.76-1.70 (2H, m, H8, H24), 1.65-1.54 (4H, m, H10, H12 × 2, H22a,), 
1.50 (3H, s, Me14), 1.40-1.20 (13H, m, H11 × 2, H17-21, H22b), 1.04 (3H, d, J = 7.3 Hz, Me24), 
0.95 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.94 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.94 (3H, obs d, 
J = 8.0 Hz, Me26), 0.88 (3H, d, J = 6.8 Hz, Me10), 0.84 (3H, d, J = 7.1 Hz, Me8), 0.59 (6H, q, J 
= 7.1 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 7.8 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) 
(C 170.9, 159.1, 146.5, 142.7, 133.6, 130.6, 130.0, 129.8, 129.2, 118.9, 113.7, 89.1, 88.1, 77.2, 
74.2, 72.8, 72.0, 70.8, 61.7, 55.5, 55.3, 41.3, 39.1, 37.1, 36.6, 36.3, 34.6, 31.7, 29.7, 29.7, 29.4, 
29.3, 28.3, 27.6, 26.1, 15.6, 14.9, 11.5, 10.2, 10.0, 7.1, 7.0, 5.6, 5.2; [!]$"# 6.0 (c 0.99, CHCl3); 
IR (thin film) n max (cm–1) 2948, 2931, 2876, 2853, 1712, 1690, 1643, 1614, 1513, 1459, 
1415, 1377, 1302, 1246, 1173, 1084, 1038, 1009, 820, 739, 727; HRMS calc. for 
















Crude seco-acid 24 (ca. 568 mg, 0.60 mmol) was dissolved in THF (15 mL) and NEt3 (836 μL, 
6.00 mmol) and TCBC (656 μL, 4.20 mmol) were added. The mixture was stirred at rt for 1 h, 
then diluted with PhMe (100 mL) and the resulting cloudy orange solution added to a solution 
of DMAP (733 mg, 6.00 mmol) in PhMe (50 mL) via syringe pump at a rate of 4.6 mL/h. Once 
complete the reaction was stirred for a further 16 h before being quenched with NH4Cl (100 
mL). The layers were separated, and the aqueous phase was extracted with EtOAc (3 × 100 
mL) and the combined organics were dried (Na2SO4) and concentrated in vacuo. Flash column 
chromatography (1:50 ® 1:9 EtOAc/PE) yielded macrocycle 25 (386 mg, 70% over two steps) 
as a colourless oil. 
 
Rf 0.52 (1:5 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 7.28 (1H, dd, J = 15.3, 10.0 Hz, H3), 
7.24 (2H, d, J = 8.9 Hz, ArH), 6.86 (2H, d, J = 8.5 Hz, ArH), 6.25-6.15 (2H, m, H4, H5), 5.83 
(1H, d, J = 15.7 Hz, H2), 5.38 (1H, dt, J = 10.8, 2.3 Hz, H23), 5.24 (1H, dd, J = 8.0, 6.0 Hz, 
H15), 4.41 (2H, ABq, J = 11.4 Hz, OCH2Ar), 3.80 (3H, s, OMe), 3.67-3.61 (1H, m, H7), 3.56-
3.50 (2H, m, H9, H27a), 3.45 (3H, s, OMe), 3.32 (1H, dd, J = 9.2, 7.2 Hz, H27b), 3.31 (1H, t, J = 
8.7 Hz, H13), 3.13 (3H, s, OMe), 2.90 (1H, dd, J = 8.3, 3.8 Hz, H25), 2.35-2.26 (1H, m, H6a), 
2.18-2.03 (3H, m, H6b, H16a, H26), 1.88-1.80 (1H, m, H16b), 1.78-1.73 (1H, m, H24), 1.73-1.64 
(2H, m, H8, H22a), 1.62-1.57 (2H, m, H10, H12a), 1.53-1.48 (1H, m, H12b), 1.48 (3H, s, Me14), 
1.43-1.33 (3H, m, H11a, H21a, H22b), 1.33-1.20 (10H, m, H11b, H17-20, H21b,), 1.06 (3H, d, J = 7.1 
Hz, Me26), 0.96 (9H, t, J = 8.2 Hz, Si(CH2CH3)3), 0.95 (9H, t, J = 8.2 Hz, Si(CH2CH3)3), 0.94 
(9H, m, Me8, Me10, Me24), 0.61 (6H, q, J = 7.8 Hz, Si(CH2CH3)3), 0.58 (6H, q, J = 7.8 Hz, 
Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) (C 167.1, 158.9, 144.8, 141.8, 133.2, 130.8, 130.0, 
129.9, 119.7, 113.6, 88.0, 85.6, 73.1, 72.6, 71.5, 61.0, 55.5, 55.1, 40.9, 40.7, 36.4, 35.9, 33.8, 
31.3, 28.9, 28.5, 28.4, 28.2, 27.8, 27.7, 27.6, 24.5, 23.8, 20.7, 17.4, 17.2, 16.1, 14.6, 11.7, 11.1, 
9.7, 7.0, 6.9, 5.3, 5.1;	[!]$"#  +10.9 (c 1.00, CHCl3); IR (thin film) vmax (cm-1) 2930, 2876, 1711, 
1643, 1614, 1580, 1513, 1458, 1367, 1300, 1245, 1171, 1134, 1091, 1038, 1001; HRMS calc. 


















To a solution of PMB ether 25 (335 mg, 0.36 mmol) in CH2Cl2 (20 mL) and pH 7.0 buffer (10 
mL) was added DDQ (164 mg, 0.72 mmol). The reaction was stirred for 2 h before being 
quenched with NaHCO3 (50 mL). The solution was diluted with H2O (100 mL) and the layers 
were separated. The aqueous phase was extracted with CH2Cl2 (3 × 100 mL) and the combined 
organics dried (Na2SO4) and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (1:50 EtOAc/PhMe ® 1:2 EtOAc/PE) to give alcohol 25a (238 mg, 
82%) as a colourless oil.  
 
Rf 0.21 (1:5 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 7.28 (1H, dd, J = 15.1, 10.3 Hz, H3), 
6.23-6.18 (2H, m, H4, H5), 5.84 (1H, d, J = 14.8 Hz, H2), 5.38 (1H, dt, J = 10.9, 2.6 Hz, H23), 
5.25 (1H, dd, J = 8.4, 5.7 Hz, H15), 3.80 (1H, dd, J = 10.9, 3.5 Hz, H27a), 3.68-3.62 (1H, m, H7), 
3.59-3.55 (2H, m, H9, H27b), 3.53 (3H, s, OMe), 3.31 (1H, dd, J = 8.4, 5.8 Hz, H13), 3.14 (3H, 
s, OMe), 3.00 (1H, dd, J = 8.1, 3.5 Hz, H25), 2.87 (1H, br s, OH), 2.35-2.27 (1H, m, H6a), 2.23-
2.06 (2H, m, H6b, H16a), 1.94-1.80 (3H, m, H16b, H24, H26), 1.77-1.64 (2H, m, H8, H22a), 1.64-
1.49 (4H, m, H10, H12 × 2, H22b), 1.47 (3H, s, Me14), 1.45-1.36 (2H, m, H11a, H21a) 1.35-1.18 
(10H, m, H11b, H17-20, H21b,), 1.13 (3H, d, J = 7.2 Hz, Me26), 0.96 (9H, t, J = 7.9 Hz, 
Si(CH2CH3)3), 0.95 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.93 (3H, obs d, Me24), 0.91 (3H, d, J = 
7.6 Hz, Me10), 0.89 (3H, d, J = 7.0 Hz, Me8), 0.60 (6H, q, J = 7.8 Hz, Si(CH2CH3)3), 0.58 (6H, 
q, J = 7.8 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) (C 167.3, 145.1, 141.8, 133.3, 130.1, 
129.9, 129.1, 128.7, 119.6, 88.7, 88.1, 77.2, 73.4, 73.1, 65.1, 61.5, 41.7, 41.1, 39.6, 36.2, 36.2, 
33.6, 31.4, 29.0, 28.6, 28.3, 27.9, 27.8, 27.7, 24.5, 16.2, 14.5, 11.7, 11.2, 9.8, 7.1, 7.0, 5.4, 5.2; 
[!]$"#  +19.2 (c 1.00, CHCl3); IR (thin film) vmax (cm-1) 3452, 2935, 2876, 1712, 1642, 1458, 
1415, 1367, 1300, 1238, 1134, 1092, 842, 739; HRMS calc. for C46H88O7Si2Na [M+Na]+ 

















To a solution of alcohol 25a (144 mg, 0.18 mmol) in CH2Cl2 (17 ml) was added DMP (377 
mg, 0.89 mmol) and NaHCO3 (74 mg, 0.89 mmol). The mixture was stirred for 2 h before 
being quenched with Na2S2O3 (50 mL). The quenching mixture was stirred for 1 h and the 
layers were separated. The aqueous phase was extracted with CH2Cl2 (3 × 50 mL) and the 
combined organics were dried (Na2SO4) and concentrated in vacuo. Aldehyde 26 was used 
immediately and crude subsequent aldol reaction.  
 
Rf 0.68 (1:1 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 9.74 (1H, d, J = 1.4 Hz, CHO), 7.29 
(1H, dd, J = 15.0, 10.0 Hz, H3), 6.27-6.15 (2H, m, H4, H5), 5.84 (1H, d, J = 14.4 Hz, H2), 5.45 
(1H, dt, J = 10.8, 2.2 Hz, H23), 5.25 (1H, dd, J = 8.4, 5.7 Hz, H15), 3.68-3.61 (1H, m, H7), 3.56-
3.49 (1H, m, H9), 3.44 (3H, s, OMe), 3.34-3.26 (2H, m, H13, H25), 3.13 (3H, s, OMe), 2.74-
2.64 (1H, m, H26), 2.37-2.25 (1H, m, H6a), 2.25-2.04 (2H, m, H6b, H16a), 1.90-1.78 (2H, m, H16b, 
H24), 1.78-1.65 (2H, m, H8, H22a), 1.65-1.49 (3H, m, H10, H12 × 2,) 1.47 (3H, s, Me14), 1.45-
1.35 (3H, m, H11a, H21a, H22b), 1.35-1.19 (10H, m, H11b, H17-20, H21b), 1.16 (3H, d, J = 7.0 Hz, 
Me26), 0.96 (18H, t, J = 7.6 Hz, Si(CH2CH3)3 × 2), 0.93 (3H, d, J = 7.2 Hz, Me10), 0.89 (3H, d, 
J = 7.0 Hz, Me8), 0.83 (3H, d, J = 7.0 Hz, Me24), 0.61 (6H, q, J = 7.9 Hz, Si(CH2CH3)3), 0.57 
(6H, q, J = 7.9 Hz, Si(CH2CH3)3). 13C NMR (125 MHz, CDCl3) (C 203.9, 167.2, 145.2, 141.9, 
133.3, 130.1, 129.9, 119.4, 88.0, 83.4, 77.2, 73.4, 72.6, 59.2, 55.4, 48.1, 40.8, 39.5, 36.4, 33.2, 
31.4, 29.7, 29.0, 28.6, 28.3, 27.8, 27.8, 27.6, 24.6, 14.5, 11.6, 10.4, 9.9, 9.8, 7.0, 7.0, 5.4, 5.2; 
[!]$"#  1.9 (c 1.00, CHCl3); IR (thin film) vmax (cm-1) 2948, 2932, 2876, 1714, 1641, 1615, 1458, 
1413, 1361, 1300, 1260, 1236, 1171, 1133, 1096, 1058, 1002, 739, 725; HRMS calc. for 























Ketone E-11 was azeotropically dried with benzene and placed under vacuum for 16 h. To a 
solution of ketone E-11 (125 mg, 0.55 mmol) in Et2O (5 mL) at 0 °C was added a freshly 
prepared solution of BCy2Cl×NEt3 (275 µL, 0.55 mmol, 2.0 M in Et2O). The resulting cloudy 
yellow solution of enolate was stirred at 0 °C for 1 h before being cooled to –78 °C. A solution 
of crude aldehyde 26 (ca. 140 mg) in Et2O (3 mL) was added and the reaction mixture was 
stirred at –78 °C for 2 h, then warmed to –10 °C over 1 h before being quenched with SiO2 (ca. 
1 g). The slurry was stirred for 1 h then filtered and rinsed with Et2O (10 mL) before being 
concentrated in vacuo. The crude material was purified by flash column chromatography 
(3:1®1:1 EtOAc/PE). As the aldol adduct and ketone E-11 were inseparable by 
chromatography, all fractions containing the intermediary aldol adduct and ketone E-11 were 
combined and used subsequently in the elimination reaction.  
To a solution of the crude aldol adduct and ketone E-11 (ca. 184 mg) in THF (6 mL) was added 
Burgess reagent (83 mg, 0.36 mmol). The reaction mixture was stirred at room temperature for 
16 h then quenched with NH4Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The combined 
organic layers were washed with brine (15 mL), dried (MgSO4) and concentrated in vacuo. The 
crude product was purified by flash column chromatography (2:1®1:1 EtOAc/PE) yielding 
enone 26a (117 mg, 65% over three steps) and recovered ketone E-11 (75 mg).  
Rf 0.89 (1:1 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 8.30 (0.60H, s, NCHO), [8.08] 
(0.30H, s, NCHO*), 7.30 (1H, dd, J = 15.4, 9.1 Hz, H3), [7.15] (0.33H, d, J = 14.6 Hz, H34*), 
6.91 (1H, dd, J = 15.1, 8.1 Hz, H27),  6.48 (0.67H, d, J = 14.3 Hz, H34), 6.25-6.10 (3H, m, H4, 
H5, H28), 5.83 (1H, d, J = 15.2 Hz, H2), 5.40 (1H, br d, J = 10.7 Hz, H23), 5.24 (1H, t, J = 6.0 
Hz, H15), 5.15 (1H, dd, J = 13.5, 9.9 Hz, H33), 3.68-3.61 (1H, m, H7), 3.56-3.51 (1H, m, H9), 
3.49 (3H, s, OMe), 3.33-3.27 (5H, m, H13, H31, OMe), 3.13 (3H, s, OMe), [3.10] (1H, s, NMe*), 
3.06 (2H, s, NMe), 3.03-2.95 (1H, m, H30), 2.95-2.89 (1H, m, H25), 2.66-2.57 (1H, m, H26), 
2.50-2.37 (1H, m, H32), 2.36-2.24 (1H, m, H6a), 2.22-2.07 (2H, m, H6b, H16a), 1.89-1.79 (1H, 
m, H16b), 1.74-1.65 (2H, m, H8, H22a), 1.64-1.57 (3H, m, H10, H12a, H24,) 1.47 (3H, s, Me14), 
1.44-1.33 (2H, m, H11a, H22b), 1.32-1.19 (11H, m, H11b, H17-21), 1.18-1.12 (6H, m, Me26, Me32), 














0.89 (3H, d, J = 7.1 Hz, Me8), 0.83 (3H, d, J = 7.4 Hz, Me24), 0.60 (6H, q, J = 7.4 Hz, 
Si(CH2CH3)3), 0.58 (6H, q, J = 7.4 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) (C [203.5], 
203.4, [167.2], 162.2, [160.9], 149.3, [149.2], 145.1, 141.9, 133.2, [130.5], 130.1, 129.9, 128.8, 
[124.7], 119.5, [113.3], 111.4, 88.0, [87.6], 87.5, 86.0, 77.1, 73.4, 72.9, 61.2, 61.1, 55.4, [46.1], 
46.0, 41.4, 39.6, 39.5, [37.9], 37.7, 36.5, 33.5, [33.0], 31.4, 29.0, 28.6, 28.3, 27.9, 27.8, 27.7, 
27.5, 24.6, 19.5, 17.4, 14.5, 13.8, [13.7], 11.7, 10.4, [10.3], 9.8, 7.1, 7.0, 5.4, 5.2; [!]$"#  -39.7 
(c 1.00, CHCl3); IR (thin film) vmax (cm-1) 2924, 2875, 1696, 1656, 1458, 1370, 1237, 1134, 
1095, 1069, 1003, 913; HRMS calc. for C58H105NO9Si2Na [M+Na]+ 1038.7220, found 
1038.7230. 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 





Stryker’s reagent solution (104 µL, 0.0026 mmol, 0.025 M in PhMe) was added to enone 26a 
(54 mg, 0.052 mmol) and the reaction mixture stirred at room temperature for 1 h. Further 
aliquots of Stryker’s reagent solution (100 µL) were added every hour for a further 4 h. The 
solution was applied directly to a silica gel column and the product eluted with EtOAc/CH2Cl2 
(1:4) to afford ketone 10 (48 mg, 89%) as a colourless oil.  
Rf 0.88 (1:1 EtOAc/PE); 1H NMR (500 MHz, CDCl3) (H 8.29 (0.67H, s, NCHO), [8.08] 
(0.33H, s, NCHO*), 7.28 (1H, dd, J = 15.4, 10.6 Hz, H3), [7.15] (0.33H, d, J = 14.6 Hz, H34*), 
6.46 (0.67H, d, J = 14.6 Hz, H34), 6.24-6.12 (2H, m, H4, H5), 5.83 (1H, d, J = 15.3 Hz, H2), 
5.42 (1H, d, J = 11.5 Hz, H23), 5.23 (1H, t, J = 8.4 Hz, H15), 5.15 (1H, dd, J = 14.6, 9.8 Hz, 
H33), 3.67-3.59 (1H, m, H7), 3.55-3.49 (1H, m, H9), 3.47 (3H, s, OMe), 3.33 (3H, s, OMe), 
3.23-3.27 (2H, m, H13, H31), 3.14 (3H, s, OMe), [3.07] (1H, s, NMe*), 3.03 (2H, s, NMe), 2.82-
2.74 (1H, m, H25), 2.72-2.62 (1H, m, H30), 2.61-2.50 (1H, m, H28a), 2.50-2.35 (2H, m, H28b, 
H32), 2.35-2.26 (1H, m, H6a), 2.16-1.97 (2H, m, H6b, H16a), 1.88-1.79 (1H, m, H16b), 1.78-1.49 
(8H, m, H8, H10, H12 ´ 2, H22a, H24, H26, H27a), 1.47 (3H, s, Me14), 1.43-1.33 (3H, m, H11a, H22b, 
H27b), 1.32-1.19 (11H, m, H17-21, H11b), 1.15 (3H, d, J = 7.5 Hz, Me32), 0.96-0.87 (33H, m, Me8, 














= 7.7 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) (C [214.3], 214.2, 167.2 162.1, [160.8], 
144.9, 134.9, 133.2, 130.2, 130.0, 128.9, [124.5], 119.8, [113.2], 111.3, 88.0, 87.4, 87.3, 74.4, 
73.4, 73.2, 61.4, 61.3, 55.5, [49.2], 49.1, 42.0, 41.0, 40.4, [37.7], 37.5, 36.5, 34.4, 33.7, [33.1], 
31.4, 29.7, 29.0, 28.6, 28.3, 28.0, 27.8, 27.7, [27.4], 24.6, 23.4, [19.4], 19.3, 17.4, 14.5, 13.6, 
13.5, 10.8, 9.8, 7.1, 7.0, 5.4, 5.2; [!]$"#  -22.5 (c 1.00, CHCl3); IR (thin film) vmax (cm-1) 2934, 
2869, 1706, 1657, 1458, 1369, 1238, 1068, 1004, 725; HRMS calc. for C58H107NO9Si2Na 
[M+Na]+ 1040.7377, found 1040.7353. 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk. 
Diol (Aplyronine C/scytophycin hybrid) 9 
 
 
A stock solution of HF·pyridine was prepared by adding HF·pyridine (100 μL) to a solution of 
pyridine (200 μL) in THF (1 mL) at 0 °C before warming to rt and stirring for 30 min. This 
solution was added to bis-TES ether 10 (8 mg, 7.9 μmol) in a plastic reaction vessel at 0 °C 
and the reaction stirred at rt overnight. The reaction was quenched at 0 °C with NaHCO3 
solution (5 mL), stirred vigorously at rt for 30 min and the aqueous phase extracted with EtOAc 
(3 × 5 mL). The combined organics were dried (Na2SO4) and concentrated in vacuo. 
Purification via flash column chromatography (1:1:0 ® 10:10:1 EtOAc/CH2Cl2/MeOH) 
yielded diol 9 (5.3 mg, 85%) as a colourless oil.  
Rf 0.52 (5:5:1 EtOAc/CH2Cl2/MeOH); 1H NMR (500 MHz, CDCl3) (H 8.29 (0.67H, s, NCHO), 
[8.07] (0.33H, s, NCHO*), 7.27 (1H, obs dd, H3), [7.13] (0.33H, d, J = 14.8 Hz, H34*), 6.46 
(0.67H, d, J = 13.6 Hz, H34), 6.28 (1H, dd, J = 15.4, 11.1 Hz, H4), 6.11 (1H, dt, J = 15.1, 7.4 
Hz, H5), 5.84 (1H, d, J = 15.0 Hz, H2), 5.35 (1H, td, J = 10.2, 2.6 Hz, H23), 5.30 (1H, t, J = 7.9 
Hz, H15), 5.11 (1H, dd, J = 14.3, 9.5 Hz, H33), 3.89-3.82 (1H, m, H7), 3.70-3.64 (1H, m, H9), 
3.46 (3H, s, OMe), 3.38-3.35 (1H, m, H13), 3.34 (3H, s, OMe), 3.31 (1H, br d, J = 9.3 Hz, H31), 
3.15 (3H, s, OMe), [3.08] (1H, s, NMe*), 3.04 (2H, s, NMe), 2.82-2.74 (2H, m, H25, OH), 2.71-
2.62 (1H, m, H30), 2.59-2.52 (3H, m, H6 × 2, H28a), 2.49-2.32 (3H, m, H28b, H32, OH), 2.09-
1.94 (2H, m, H16 × 2), 1.80-1.54 (8H, m, H8, H10, H12 ´ 2, H22a, H24, H26, H27a), 1.53-1.47 (1H, 














1.16 (3H, d, J = 6.8 Hz, Me32), 1.04 (3H, d, J = 7.1 Hz, Me24), 0.97 (3H, d, J = 6.8 Hz, Me8), 
0.90 (3H, d, J = 7.1 Hz, Me30), 0.90 (3H, d, J = 7.1 Hz, Me26), 0.79 (3H, d, J = 7.2 Hz, Me10); 
13C NMR (125 MHz, CDCl3) (C [214.3], 214.2, 167.0 162.2, [160.9], 144.3, 138.9, 133.7, 
131.0, 129.9, 128.8, [124.7], 120.6, [113.3], 111.4, 87.9, 87.5, 87.3, 75.3, 75.2, 73.8, 61.4, 61.3, 
55.7, 49.1, 42.1, 40.7, 39.0, [37.7], 37.5, 37.0, 34.5, 33.7, [33.1], 30.9, 29.7, 28.8, 28.7, 28.5, 
27.8, 27.6, 27.3, 25.1, 23.5, 19.5, 17.4, 15.8, 13.5, 11.6, 10.9, 10.3; [!]$"#  -46.8 (c 0.21, CHCl3); 
IR (thin film) vmax (cm-1) 3349, 2939, 2853, 1703, 1655, 1461, 1360, 1277, 1134, 1065, 1002, 
970, 800, 725; HRMS calc. for C46H79NO9Na [M+Na]+ 812.5647, found 812.5643. 
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 




(S)-Trimethyl serine (3.9 mg, 26.5 μmol) and DMAP (3.2 mg, 26.3 μmol) were dissolved in 
CH2Cl2 (3 mL), then TCBC (8 μL, 51.1 μmol) and NEt3 (11 μL, 78.9 μmol) were added to 
form a stock solution of mixed anhydride. Diol 9 (2 mg, 2.65 μmol) was dissolved in benzene 
(0.30 mL) and an aliquot of the stock solution (0.30 mL) was added at 0 °C. Further aliquots 
of stock solution (0.15 mL) were added hourly for 4 h. The reaction was then quenched with 
MeOH (0.5 mL) and concentrated in vacuo. The crude residue was purified by preparative thin 
layer chromatography (4:4:1 EtOAc/CH2Cl2/MeOH) to give ester S-8 as a colourless oil (1.5 
mg, 62%). 
 
Rf 0.57 (4:4:1 EtOAc/CH2Cl2/MeOH); 1H NMR (500 MHz, CDCl3) (H 8.29 (0.67H, s, NCHO), 
[8.07] (0.33H, s, NCHO*), 7.23 (1H, obs dd, H3), [7.12] (0.33H, d, J = 14.8 Hz, H34*), 6.45 
(0.67H, d, J = 14.2 Hz, H34), 6.26 (1H, dd, J = 14.7, 11.2 Hz, H4), 6.04 (1H, dt, J = 14.7, 6.7 
Hz, H5), 5.86 (1H, d, J = 15.1 Hz, H2), 5.38 (1H, br d, J = 10.8 Hz, H23), 5.28 (1H, t, J = 7.5 



















Hz, H3’a), 3.64 (1H, dd, J = 8.3, 4.0 Hz, H3’b), 3.61-3.58 (1H, m, H9), 3.46 (3H, s, OMe), 3.42-
3.39 (1H, m, H2’), 3.38-3.35 (4H, m, H13, OMe), 3.34 (3H, s, OMe), 3.31 (1H, br d, J = 9.1 Hz, 
H31), 3.14 (3H, s, OMe), [3.08] (1H, s, NMe*), 3.04 (2H, s, NMe), 2.78 (1H, dt, J = 9.1, 2.5 
Hz, H25), 2.72-2.61 (1H, m, H30), 2.61-2.51 (2H, m, H6a, H28a), 2.50-2.40 (3H, m, H6b, H28b, 
H32), 2.40-2.35 (7H, m, OH, C2’NMe2), 1.95-1.90 (2H, m, H16 × 2), 1.80-1.70 (3H, m, H24, H26, 
H27a) 1.65-1.58 (3H, m, H10, H12 ´ 2), 1.50 (3H, s, Me14), 1.46-1.35 (4H, m, H11a, H22 ´ 2, H27b), 
1.35-1.19 (11H, m, H11b, H17-21,), 1.16 (3H, d, J = 6.9 Hz, Me32), 0.99-0.95 (6H, m, Me8, Me10), 
0.92 (3H, d, J = 6.5 Hz, Me30), 0.90 (3H, d, J = 6.1 Hz, Me24), 0.88 (3H, d, J = 6.9 Hz, Me26); 
13C NMR (125 MHz, CDCl3) (C [214.3], 214.2, 170.2, 167.0, 162.2, [160.9], 144.0, 137.8, 
133.8, 131.4, 129.9, 128.7, 128.2,  [124.7], 121.2, [113.2], 111.4, 87.8, 87.4, 87.4, 87.3, 74.0, 
73.7, 70.5, 67.6, 67.4, 61.4, [61.3], 59.2, 55.6, [49.2], 49.1, 42.5, 42.4, 42.1, [40.8], 40.8, [37.7], 
37.5, 36.7, 36.4, 34.6, 34.5, 33.8, [33.1], 31.6, 29.7, 29.4, 28.9, 28.4, 28.1, 27.7, 27.6, 27.4, 
22.7, [22.7], [19.4], 19.4, 17.4, 15.5, 13.5, 11.8, 10.9, 10.1; [!]$"#  -22.1 (c 0.032, CHCl3); IR 
(thin film) vmax (cm-1) 3390, 2451, 2896, 2853, 1711, 1678, 1651, 1462, 1360, 1272, 1220, 1079, 
1002, 957, 891, 829, 701; HRMS calc. for C52H90N2O11K [M+K]+ 957.6176, found 957.6189. 
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 





(R)-Trimethyl serine (3.9 mg, 26.5 μmol) and DMAP (3.2 mg, 26.3 μmol) were dissolved in 
CH2Cl2 (3 mL), then TCBC (8 μL, 51.1 μmol) and NEt3 (11 μL, 78.9 μmol) were added to 
form a stock solution of mixed anhydride. Diol 9 (2.1 mg, 2.67 μmol) was dissolved in benzene 
(0.30 mL) and an aliquot of the stock solution (0.30 mL) was added at 0 °C. Further aliquots 
of stock solution (0.30 mL) were added every 30 min for 1.5 h. The reaction was then quenched 



















column chromatography (1:1:0 ® 4:4:1 EtOAc/CH2Cl2 /MeOH) to give ester R-8 as a 
colourless oil (1.8 mg, 73%). 
 
Rf 0.42 (5:5:1 EtOAc/CH2Cl2/MeOH); 1H NMR (500 MHz, CDCl3) (H 8.29 (0.67H, s, NCHO), 
[8.07] (0.33H, s, NCHO*), 7.26 (1H, obs dd, H3), [7.13] (0.33H, d, J = 14.0 Hz, H34*), 6.46 
(0.67H, d, J = 14.1 Hz, H34), 6.26 (1H, dd, J = 14.6, 11.9 Hz, H4), 6.06-6.00 (1H, m, H5), 5.86 
(1H, d, J = 15.5 Hz, H2), 5.38 (1H, br d, J = 10.7 Hz, H23), 5.32-5.26 (1H, m, H15), 5.09 (1H, 
dd, J = 14.3, 9.1 Hz, H33), 4.99-4.95 (1H, m, H7), 3.69 (2H, app d, J = 6.4 Hz, H3’ ´ 2), 3.59-
3.56 (1H, m, H9), 3.46 (3H, s, OMe), 3.46-3.40 (1H, m, H2’), 3.37-3.35 (4H, m, H13, OMe), 
3.34 (3H, s, OMe), 3.31 (1H, br d, J = 10.9 Hz, H31), 3.14 (2H, s, OMe), [3.12] (1H, s, OMe*), 
[3.08] (1H, s, NMe*), 3.04 (2H, s, NMe), 2.78 (1H, dt, J = 8.2, 3.1 Hz, H25), 2.72-2.62 (1H, m, 
H30), 2.61-2.42 (5H, m, H6 ´ 2, H28 ´ 2, H32), 2.40-2.35 (7H, m, OH, C2’NMe2), 1.96-1.90 (2H, 
m, H16 × 2), 1.82-1.71 (3H, m, H24, H26, H27a) 1.65-1.59 (3H, m, H10, H12 ´ 2), 1.51 (3H, s, 
Me14), 1.43-1.35 (4H, m, H11a, H22 ´ 2, H27b), 1.35-1.17 (11H, m, H11b, H17-21,), 1.15 (3H, d, J 
= 7.0 Hz, Me32), 0.99-0.95 (6H, m, Me8, Me10), 0.92 (3H, d, J = 6.6 Hz, Me30), 0.90 (3H, d, J 
= 6.4 Hz, Me24), 0.88 (3H, d, J = 7.0 Hz, Me26); 13C NMR (125 MHz, CDCl3) (C [214.3], 
214.2, 169.9, 166.9, 162.2, [160.8], 143.8, 138.8, 137.6, 133.8, 132.1, 131.5, 129.9, 128.7, 
128.5, 127.7, 125.0, [124.7], 121.2, [113.2], 111.4, 87.8, 87.4, 87.4, 87.3, 74.0, 73.7, 71.3, 67.2, 
61.4, [61.4], 61.3, 59.1, 55.6, [49.2], 49.1, 42.3, 42.1, 40.8, [37.7], 37.5, 36.6, 36.3, 34.6, 34.5, 
33.8, [33.1], 30.5, 29.7, 29.4, 29.0, 28.4, 28.2, 27.7, 27.6, 27.5, 22.7, [19.4], 19.4, 17.4, 15.5, 
[13.6], 13.5, 11.6, 10.9, [10.9], 10.1; [!]$"#  -7.1 (c 0.028, CHCl3); IR (thin film) vmax  (cm-1) 
3392, 2896, 2846, 1710, 1675, 1651, 1461, 1343, 1288, 1221, 1082, 1003, 960, 892, 829, 700; 
HRMS calc. for C52H90N2O11Na [M+Na]+ 941.6442, found 941.6402. 
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 









Zn(BH4)2 solution (1.12 mL, 0.175 M in Et2O, 0.196 mmol) was added to ketone 10 (20 mg, 
0.0196 mmol) at 0 °C and the reaction stirred at this temperature for 5 h before being quenched 
with NH4Cl (5 mL) and Na+/K+ tartrate solution (10 mL). The quenching mixture was stirred 
vigorously for 3 h then extracted with CH2Cl2 (3 × 10 mL). The combined organics were dried 
over Na2SO4 and concentrated in vacuo. The crude product was purified by flash 
chromatography (1:0 ® 4:1 ® 1:1 CH2Cl2/EtOAc) to yield alcohol 27a as a colourless oil 
(11.5 mg, 58%, 2:1 dr).  
Rf  0.45 (1:2 EtOAc/CH2Cl2); 1H NMR (500 MHz, CDCl3) (H 8.29 (0.66H, s, NCHO), [8.07] 
(0.33H, s, NCHO*), 7.28 (1H, dd, J = 15.2, 9.8 Hz, H3), [7.15] (0.33H, d, J = 14.7 Hz, H34*), 
6.49 (0.66H, d, J = 14.3 Hz, H34), 6.24-6.14 (2H, m, H4, H5), 5.84 (1H, d, J = 15.1 Hz, H2), 
5.42 (1H, dd, J = 10.9, 2.0 Hz, H23), 5.24 (1H, t, J = 7.8 Hz, H15), [5.15] (0.37H, dd, J = 15.2, 
8.8 Hz, H33*), 5.07 (0.60H, dd, J = 14.2, 8.3 Hz, H33), 3.90-3.83 (1H, m, H29), 3.67-3.61 (1H, 
m, H7), 3.55-3.40 (1H, m, H9), 3.48 (3H, s, OMe), 3.46 (3H, s, OMe), 3.30 (1H, dd, J = 8.1, 
5.9 Hz, H13), [3.06] (1H, s, NMe*), 3.02 (2H, s, NMe), 3.01 (1H, obs dd, H31), 2.79 (1H, dd, J 
= 11.0, 2.1 Hz, H25), 2.60-2.46 (1H, m, H32), 2.38-2.27 (1H, m, H6a), 2.17-2.00 (3H, m, H6b, 
H16 ´ 2), 1.88-1.77 (1H, m, H22a), 1.75-1.61 (4H, m, H8, H22b, H24, H26), 1.61-1.55 (4H, m, H10, 
H12 ´ 2, H30), 1.51-1.48 (2H, m, H28 ´ 2), 1.47 (3H, s, Me14), 1.43-1.33 (4H, m, H11 ´ 2, H27 ´ 
2), 1.31-1.20 (10H, m, H17-21), [1.10] (1H, d, J = 6.7 Hz, Me32*), 1.07 (2H, d, J = 6.7 Hz, Me32), 
1.00 (3H, d, J = 6.7 Hz, Me26), 0.97 (3H, obs d, Me8), 0.96 (9H, t, J = 8.3 Hz, Si(CH2CH3)3), 
0.95 (9H, t, J = 8.3 Hz, Si(CH2CH3)3), 0.92-0.86 (9H, m, Me10, Me24, Me30), 0.60 (6H, q, J = 
8.0 Hz, Si(CH2CH3)3), 0.58 (6H, q, J = 8.0 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) 
(C 167.3, 162.2, [160.8], 144.9, 135.2, 134.5, 133.1, 132.1, 131.9, 130.1, 129.9, 128.5, 125.0, 
[124.5], 122.3, 119.8, 114.5, [113.0], 90.5, 90.1, 88.0, [87.6], 87.5, 74.3, 73.6, 73.3, 71.8, 71.5, 
61.9, [61.2], 55.4, [40.9], 40.4, 40.1, 39.3, 38.8, 38.1, 35.5, 33.7, [33.1], 31.9, 31.4, 30.7, 29.7, 
29.6, 29.1, 28.9, 28.7, 28.3, 27.9, 27.7, 27.5, 26.6, 25.7, 24.6, 23.4, 22.7, 18.8, 17.7, 14.5, 14.1, 














3445, 2933, 2876, 1698, 1657, 1461, 1240, 1225, 1006, 727, 669; HRMS calc. for 
C58H109NO9Si2Na [M+Na]+ 1042.7533, found 1042.7539. 
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 






To a solution of alcohol 27 (2 mg, 1.96 μmol) in CH2Cl2 (0.10 mL) was added DMAP (1 
crystal), DMAP hydrochloride (1 crystal), DCC (7 μL, 1M in CH2Cl2, 9.82 μmol) and (R)-(-)-
MTPA OH (2 mg, 9.82 μmol) and the mixture was stirred for 16 h. Once complete, the reaction 
was purified by flash column chromatography (1:4 EtOAc/CH2Cl2) to give (R)-Mosher ester 
R-MTPA-27a as a colourless oil (1.5 mg, 63%). The corresponding (S)-Mosher ester was 
synthesised from 27a (1.8 mg, 1.77 μmol) to generate S-MTPA-27a as a colourless oil (1.6 mg, 
72%). 
S-MTPA-27a 
Rf  0.78 (1:3 EtOAc/CH2Cl2); 1H NMR (500 MHz, CDCl3) (H 8.27 (0.66H, s, NCHO), [8.05] 
(0.33H, s, NCHO*), 7.62-7.56 (2H, m, ArH), 7.43-7.37 (3H, m, ArH), 7.29 (1H, obs dd, H3), 
[7.10] (0.33H, d, J = 14.5 Hz, H34*), 6.41 (0.66H, d, J = 14.5 Hz, H34), 6.24-6.14 (2H, m, H4, 
H5), 5.83 (1H, d, J = 15.5 Hz, H2), 5.39 (1H, dd, J = 10.7, 2.4 Hz, H23), 5.35 (1H, app q, J = 
8.4 Hz, H29), 5.24 (1H, t, J = 8.2 Hz, H15), [5.10] (0.37H, dd, J = 14.3, 8.2 Hz, H33*), 5.04 (0.6H, 
dd, J = 14.7, 8.2 Hz, H33), 3.67-3.59 (1H, m, H7), 3.57 (3H, s, OMe), 3.55-3.40 (1H, m, H9), 
3.45 (3H, s, OMe), 3.39 (3H, s, OMe), 3.31 (1H, dd, J = 8.4, 5.7 Hz, H13), 3.15 (3H, s, OMe), 
[3.03] (1H, s, NMe*), 3.00 (2H, s, NMe), 2.75 (1H, dt, J = 8.9, 2.2 Hz, H25), 2.64 (1H, td, J = 
9.6, 1.7 Hz, H31), 2.41-2.24 (3H, m, H6 ´ 2, H32), 2.17-2.08 (2H, m, H16 ´ 2), 1.90-1.72 (2H, m, 
H8, H22a), 1.65-1.55 (7H, m, H10, H12 ́  2, H22b, H24, H26, H30), 1.51-1.44 (5H, m, H28 ́  2, Me14), 
1.43-1.35 (4H, m, H11 ´ 2, H27 ´ 2), 1.32-1.22 (10H, m, H17-21,), 1.09 (3H, d, J = 6.8 Hz, Me32), 
















0.95 (9H, t, J = 8.2 Hz, Si(CH2CH3)3), 0.89 (3H, d, J = 6.6 Hz, Me24), 0.84 (3H, d, J = 6.6 Hz, 
Me10), 0.76 (3H, d, J = 6.6 Hz, Me30), 0.60 (6H, q, J = 8.2 Hz, Si(CH2CH3)3), 0.58 (6H, q, J = 
8.2 Hz, Si(CH2CH3)3). 
R-MTPA-27a 
Rf  0.78 (1:3 EtOAc/CH2Cl2); 1H NMR (500 MHz, CDCl3) (H 8.27 (0.66H, s, NCHO), [8.05] 
(0.33H, s, NCHO*), 7.61-7.56 (2H, m, ArH), 7.44-7.37 (3H, m, ArH), 7.30 (1H, obs dd, H3), 
[7.11] (0.33H, d, J = 14.7 Hz, H34*), 6.43 (0.66H, d, J = 14.5 Hz, H34), 6.24-6.14 (2H, m, H4, 
H5), 5.84 (1H, d, J = 15.1 Hz, H2), 5.38 (1H, dd, J = 10.9, 2.1 Hz, H23), 5.36 (1H, app q, J = 
8.4 Hz, H29), 5.24 (1H, t, J = 7.4 Hz, H15), [5.13] (0.47H, dd, J = 15.2, 8.8 Hz, H33*), 5.06 (1H, 
dd, J = 13.9, 7.9 Hz, H33), 3.68-3.61 (1H, m, H7), 3.56-3.51 (1H, m, H9), 3.49 (3H, s, OMe), 
3.47 (3H, s, OMe), 3.38 (3H, s, OMe), 3.31 (1H, dd, J = 8.2, 5.9 Hz, H13), 3.15 (3H, s, OMe), 
[3.04] (1H, s, NMe*), 3.00 (2H, s, NMe), 2.74 (1H, dt, J = 8.8, 2.7 Hz, H25), 2.65 (1H, td, J = 
9.6, 1.7 Hz, H31), 2.43-2.22 (3H, m, H6 ´ 2, H32), 2.15-2.08 (2H, m, H16 ´ 2), 1.91-1.71 (2H, m, 
H8, H22a), 1.65-1.55 (7H, m, H10, H12 ́  2, H22b, H24, H26, H30), 1.54-1.43 (4H, m, H28 ́  2, Me14), 
1.42-1.36 (4H, m, H11 ´ 2, H27 ´ 2), 1.32-1.22 (10H, m, H17-21,), 1.10 (3H, d, J = 6.8 Hz, Me32), 
0.99 (3H, d, J = 7.0 Hz, Me26), 0.97 (3H, obs d, Me8), 0.96 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 
0.95 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.87 (3H, d, J = 6.6 Hz, Me24), 0.84 (3H, d, J = 6.6 Hz, 
Me10), 0.78 (3H, d, J = 6.6 Hz, Me30), 0.60 (6H, q, J = 8.1 Hz, Si(CH2CH3)3), 0.58 (6H, q, J = 
8.1 Hz, Si(CH2CH3)3). 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 
Table 2. Diagnostic 1H NMR signals for the configurational assignment of 29R 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H23 5.39 5.38 +0.01 
Me24 0.89 0.87 +0.02 
H25 2.75 2.74 +0.01 
H29 5.35 5.36 –0.01 
Me30 0.76 0.78 –0.02 
H31 2.64 2.65 –0.01 






DMAP (11 mg, 8.8 µmol), DMAP hydrochloride (14 mg, 8.8 µmol), dimethylglycine (9 mg, 
8.8 µmmol) and alcohol 27a (9 mg, 8.8 µmmol) were dissolved in CH2Cl2 (0.50 mL). DCC 
(88 µL, 8.8 µmol, 1M in CH2Cl2) was added and the reaction stirred for 16 h before being 
quenched with NaHCO3 (2 mL). The layers were separated, and the aqueous phase extracted 
with CH2Cl2 (3 × 5 mL). The combined organics were dried (Na2SO4), concentrated in vacuo 
and the crude material transferred to a plastic reaction vessel.  
A stock solution of HF·pyridine was prepared by adding HF·pyridine (100 μL) to a solution of 
pyridine (200 μL) in THF (1 mL) at 0 °C before warming to rt and stirring for 30 min. This 
solution was added the crude material 0 °C and the reaction stirred at rt overnight. The reaction 
was quenched at 0 °C with NaHCO3 solution (5 mL), stirred vigorously at rt for 30 min and 
the aqueous phase extracted with EtOAc (3 × 5 mL). The combined organics were dried 
(Na2SO4) and concentrated in vacuo. Purification via flash column chromatography (1:1:0 ® 
4:4:1 EtOAc/CH2Cl2/MeOH) yielded diol 27 (5.3 mg, 69%) as a colourless oil.  
Rf 0.45 (4:4:1 EtOAc/CH2Cl2/MeOH); 1H NMR (500 MHz, CDCl3) (H 8.28 (0.66H, s, NCHO), 
[8.06] (0.33H, s, NCHO*), 7.27 (1H, obs dd, H3), [7.12] (0.33H, d, J = 14.5 Hz, H34*), 6.45 
(0.66H, d, J = 14.5 Hz, H34), 6.28 (1H, dd, J = 15.3, 11.0 Hz, H4), 6.12 (1H, dt, J = 15.2, 7.8 
Hz, H5), 5.84 (1H, d, J = 15.7 Hz, H2), 5.35-5.27 (2H, m, H23, H29), 5.24 (1H, t, J = 6.9 Hz, 
H15), 5.11 (1H, dd, J = 14.5, 10.0 Hz, H33), 3.88-3.80 (1H, m, H7), 3.70-3.59 (1H, m, H9), 3.53-
3.46 (2H, m, H2’’ ´ 2), 3.44 (3H, s, OMe), 3.43 (3H, s, OMe), 3.41 (1H, obs dd, H13), 3.15 (3H, 
s, OMe), [3.05] (1H, s, NMe*), 3.00 (2H, s, NMe), 2.81 (1H, dd, J = 9.8, 2.1 Hz, H25), 2.75 
(1H, dd, J = 8.4, 2.4 Hz, H31), 2.59-2.42 (3H, m, H6 ´ 2, H32), 2.39 (6H, s, C2’’NMe2), 2.10-
1.99 (2H, m, H16 ´ 2), 1.73-1.65 (6H, m, H8, H22a, H24, H26, H28 ´ 2), 1.64-1.51 (5H, m, H10, 
H12 ´ 2, H22b, H30), 1.38-1.31 (4H, m, H11 ´ 2, H27 ´ 2), 1.48 (3H, s, Me14), 1.30-1.19 (10H, m, 
H17-21,), 1.16 (3H, d, J = 6.6 Hz, Me32), 1.04 (3H, d, J = 6.6 Hz, Me8), 0.97 (3H, d, J = 7.4 Hz, 
Me26), 0.88-0.82 (6H, m, Me10, Me24), 0.79 (3H, d, J = 7.4 Hz, Me30); 13C NMR (125 MHz, 
CDCl3) (C 170.2, 167.0, 162.2, [160.9], 156.7, 144.3, 139.0, 133.7, 130.9, 129.9, 128.8, 128.6, 
[124.6], 120.5, [113.4], 111.7, 87.9, 87.3, 86.6, 75.3, 74.0, 73.9, 61.3, [61.1], 60.3, 55.6, 49.1, 
















28.7, 28.5, 27.8, 27.6, 27.3, 24.9, 20.3, [17.4], 17.3, 15.7, [11.6], 11.1, 10.3, 9.8, 9.7; [!]$"#  
-13.9 (c 0.16, CHCl3); IR (thin film) vmax (cm-1) 3325, 2952, 2853, 1708, 1690, 1656, 1635, 
1559, 1448, 1254, 1159, 1091 975; HRMS calc. for C50H88N2O10Na [M+Na]+ 899.6337, found 
899.6324. 
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 
assignments denoted with an asterisk.  
 




(S)-Trimethyl serine (6.7 mg, 46.1 μmol) and DMAP (5.6 mg, 46.1 μmol) were dissolved in 
CH2Cl2 (3 mL) and TCBC (15 μL, 92.3 μmol) and NEt3 (13 μL, 92.3 μmol) were added to 
form a stock solution of mixed anhydride. Diol 27 (2 mg, 46.1 μmol) was dissolved in benzene 
(0.30 mL) and an aliquot of the stock solution (0.40 mL) was added at 0 °C. Further aliquots 
of stock solution (0.40 mL) were added every 30 min for 2 h. The reaction was then quenched 
with MeOH (1.5 mL) and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (1:0:0 ® 1:1:0 ® 4:4:1 CH2Cl2/EtOAc/MeOH) to give aplyrologue 
D (7) as a colourless oil (1.4 mg, 65%). 
 
Rf 0.31 (4:4:1 EtOAc/CH2Cl2/MeOH); 1H NMR (500 MHz, CDCl3) (H 8.28 (0.66H, s, NCHO), 
[8.06] (0.33H, s, NCHO*), 7.24 (1H, obs dd, H3), [7.12] (0.33H, d, J = 14.4 Hz, H34*), 6.46 
(0.66H, d, J = 14.2 Hz, H34), 6.28 (1H, dd, J = 14.8, 11.1 Hz, H4), 6.03 (1H, dt, J = 15.2, 7.8 
Hz, H5), 5.86 (1H, d, J = 15.4 Hz, H2), 5.34 (1H, dt, J = 9.5, 2.4 Hz, H15), 5.31-5.25 (2H, m, 
H23, H29), 5.08 (1H, dd, J = 14.6, 9.4 Hz, H33), 5.01-4.95 (1H, m, H7), 3.82-3.68 (2H, m, H3’ ´ 
2, H2’’ ´ 2), 3.60-3.55 (1H, m, H9), 3.44 (3H, s, OMe), 3.43 (3H, s, OMe), 3.37 (3H, s, OMe) 
3.42-3.38 (1H, m, H2’), 3.35 (1H, br d, J = 6.4 Hz, H13), 3.15 (3H, s, OMe), [3.05] (1H, s, 
NMe*), 3.00 (2H, s, NMe), 2.81 (1H, dd, J = 9.1, 2.5 Hz, H25), 2.76 (1H, dd, J = 8.4, 2.7 Hz, 
H31), 2.58 (6H, s, C2’ NMe2), 2.52 (7H, s, C2’’NMe2, H32), 2.50-2.41 (2H, m, H6 ´ 2), 1.96-1.86 
(2H, m, H16 ´ 2), 1.72-1.66 (4H, m, H8, H22a, H24, H26,), 1.64-1.53 (7H, m, H10, H12 ´ 2, H22b, 





















21,), 1.15 (3H, d, J = 6.6 Hz, Me32), 0.98 (6H, d, J = 7.4 Hz, Me8, Me26), 0.88 (3H, d, J = 6.8 
Hz, Me10), 0.86 (3H, d, J = 6.8 Hz, Me24),  0.83 (3H, d, J = 7.0 Hz, Me30); 13C NMR (125 
MHz, CDCl3) (C 169.1, [168.5], 166.9, 162.2, 160.9, 143.9, 137.7, 135.2, 133.8, 131.4, 129.9, 
128.7, 127.6, 125.0, [124.7], 121.1, [113.6], 111.7, 87.7, [87.3], 86.6, 74.1, 73.7, 70.3, 67.0, 
61.9, 61.3, [61.3], 59.2, 55.6, 49.2, 45.2, 42.2, 40.8, 39.2, 39.0, 38.1, 37.8, 36.5, 35.2, 34.3, 
33.9, 33.7, [33.1], 30.4, 29.7, 29.4, 29.0, 28.4, 28.1, 27.8, 27.6, 27.5, 26.4, 25.9, 23.4, 22.7, 
20.1, 17.6, [17.5], 15.5, 14.1, [11.6], 11.1, 10.2, 9.9, 9.8; [!]$"#  -4.5 (c 0.056, CHCl3); IR (thin 
film) vmax (cm-1) 3456, 2940, 2925, 2912, 1714, 1692, 1649, 1613, 1546, 1454, 1368, 1258, 
1218, 1129, 1094, 852, 820, 780, 731; HRMS calc. for C55H98N3O11 [M+H]+ 992.7151 found 
992.7126. 
 
Distinguishable resonances of the minor rotamer (2:1 ratio) are given in brackets and 




4. Experimental Procedures for Cell Viability Studies 
 
4.1. Cell viability studies  
 
HeLa cells were obtained from the American Type Culture Collection (ATCC) and were 
maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% heat-
inactivated FBS and 2 mM L-glutamine. 
 
Cells were seeded at 2,000 cells/well in 96-well plates for 24 h at 37 °C with 5% CO2. Serial 
dilutions of aplyronines (1-3) and their analogues (7-9) were added to the cells in complete 
growth medium and incubated at 37 °C with 5% CO2 for 96 h. Cell viability was measured 
using CellTiter-Glo viability assay (Promega) according to the manufacturer’s instructions. 
Cell viability was plotted as a percentage of untreated cells. Each measurement was taken in 
triplicate and three independent repeats were performed from different cell passages. 
Discodermolide was used as an external control between all tests. 
 
  
4.2. Cytotoxicity graphs  
 
 
Figure 4. Graph showing cell viability as a function of log[drug] for 7 (aplyrologue D), S-/R-8 (aplyronine A,D/scytophycin 
hybrid) and 9 (aplyronine C/scytophcin hybrid). Discodermolide was included as an external control 
 
 
Figure 5. Graph showing cell viability as a function of log[drug] for synthetic aplyronines A (1), C (2) and D (3)8,9. 
Discodermolide was included as an external control  
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1H and 13C NMR spectra of all new compounds are presented below. 
 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
15: 1H NMR (500 MHz)
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
15: 13C NMR (125 MHz)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
16: 1H NMR (500 MHz)
-10190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
16: 13C NMR (125 MHz)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
16a: 1H NMR (500 MHz)
-10190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
16a: 13C NMR (125 MHz)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
16b: 1H NMR (500 MHz)
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
16b: 13C NMR (125 MHz)
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
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13C NMR 125 MHz
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
22: 1H NMR (500 MHz)
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
22: 13C NMR (125 MHz)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
22a: 1H NMR (500 MHz)
-10190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
22a: 13C NMR (125 MHz)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
23: 1H NMR (500 MHz)
-10190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
23: 13C NMR (500 MHz)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
23a: 1H NMR (500 MHz)
-10190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
23a: 13C NMR (125 MHz)
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
23b: 1H NMR (500 MHz)
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
23b: 13C NMR (125 MHz)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
24: 1H NMR (500 MHz)
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
24: 13C NMR (125 MHz)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
25: 1H NMR (500 MHz)
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
25: 13C NMR (125 MHz)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
25a: 1H NMR (500 MHz)
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
25a: 13C NMR (125 MHz)
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
26: 1H NMR (500 MHz)
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
26: 13C NMR (125 MHz)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
26a: 1H NMR (500 MHz)
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
26a: 13C NMR (125 MHz)
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
10: 1H NMR (500 MHz)
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
10: 13C NMR (125 MHz)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
9: 1H NMR (500 MHz)
Aplyronine C/
scytophycin hybrid
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm




































R-8: 13C NMR (125 MHz)
Aplyronine A,D/scytophycin hybrid
S-8: 1H NMR (500 MHz)
Aplyronine A,D/scytophycin hybrid
2030405060708090100110120130140150160170180190200210 ppm





































































































7: 13C NMR (125 MHz)
Aplyrologue D 
